CN107019186A - 一种含蜂花粉的膳食营养补充剂 - Google Patents
一种含蜂花粉的膳食营养补充剂 Download PDFInfo
- Publication number
- CN107019186A CN107019186A CN201710217393.5A CN201710217393A CN107019186A CN 107019186 A CN107019186 A CN 107019186A CN 201710217393 A CN201710217393 A CN 201710217393A CN 107019186 A CN107019186 A CN 107019186A
- Authority
- CN
- China
- Prior art keywords
- parts
- seed
- bee pollen
- dietary supplement
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 57
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000000463 material Substances 0.000 claims abstract description 35
- 239000002994 raw material Substances 0.000 claims abstract description 31
- 238000005516 engineering process Methods 0.000 claims abstract description 27
- 239000003595 mist Substances 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 229960003080 taurine Drugs 0.000 claims abstract description 21
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 20
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 20
- 235000008434 ginseng Nutrition 0.000 claims abstract description 20
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002131 composite material Substances 0.000 claims abstract description 11
- 238000007710 freezing Methods 0.000 claims abstract description 5
- 230000008014 freezing Effects 0.000 claims abstract description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 69
- 210000004369 blood Anatomy 0.000 claims description 65
- 239000008280 blood Substances 0.000 claims description 65
- 210000000582 semen Anatomy 0.000 claims description 50
- -1 ange Species 0.000 claims description 35
- 238000000227 grinding Methods 0.000 claims description 29
- 240000008866 Ziziphus nummularia Species 0.000 claims description 28
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 26
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 23
- 235000008708 Morus alba Nutrition 0.000 claims description 22
- 240000000249 Morus alba Species 0.000 claims description 22
- 238000002360 preparation method Methods 0.000 claims description 22
- 239000002245 particle Substances 0.000 claims description 21
- 240000004307 Citrus medica Species 0.000 claims description 20
- 235000004347 Perilla Nutrition 0.000 claims description 20
- 244000124853 Perilla frutescens Species 0.000 claims description 19
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 19
- 244000144725 Amygdalus communis Species 0.000 claims description 18
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 18
- 241000282994 Cervidae Species 0.000 claims description 18
- 240000008669 Hedera helix Species 0.000 claims description 18
- 240000004371 Panax ginseng Species 0.000 claims description 18
- 235000020224 almond Nutrition 0.000 claims description 18
- 241000219784 Sophora Species 0.000 claims description 17
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 16
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 16
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 16
- 235000008397 ginger Nutrition 0.000 claims description 16
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 15
- 244000012254 Canarium album Species 0.000 claims description 15
- 235000009103 Canarium album Nutrition 0.000 claims description 15
- 241000220261 Sinapis Species 0.000 claims description 15
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 14
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 14
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 14
- 244000077995 Coix lacryma jobi Species 0.000 claims description 13
- 241000208688 Eucommia Species 0.000 claims description 13
- 244000194101 Ginkgo biloba Species 0.000 claims description 13
- 235000015468 Lycium chinense Nutrition 0.000 claims description 13
- 244000241872 Lycium chinense Species 0.000 claims description 13
- 241000237502 Ostreidae Species 0.000 claims description 13
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 13
- 235000020636 oyster Nutrition 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 13
- 239000003826 tablet Substances 0.000 claims description 13
- 235000006487 Euryale ferox Nutrition 0.000 claims description 12
- 244000268590 Euryale ferox Species 0.000 claims description 12
- 244000246386 Mentha pulegium Species 0.000 claims description 12
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 12
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 12
- 244000131360 Morinda citrifolia Species 0.000 claims description 12
- 235000021282 Sterculia Nutrition 0.000 claims description 12
- 240000001058 Sterculia urens Species 0.000 claims description 12
- 235000001050 hortel pimenta Nutrition 0.000 claims description 12
- 235000017524 noni Nutrition 0.000 claims description 12
- 229940059107 sterculia Drugs 0.000 claims description 12
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 11
- 108010010803 Gelatin Proteins 0.000 claims description 11
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- 244000068988 Glycine max Species 0.000 claims description 11
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 11
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 11
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 11
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 11
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 11
- 244000046146 Pueraria lobata Species 0.000 claims description 11
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 11
- 240000007651 Rubus glaucus Species 0.000 claims description 11
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 11
- 229920000159 gelatin Polymers 0.000 claims description 11
- 239000008273 gelatin Substances 0.000 claims description 11
- 235000019322 gelatine Nutrition 0.000 claims description 11
- 235000011852 gelatine desserts Nutrition 0.000 claims description 11
- 239000006041 probiotic Substances 0.000 claims description 11
- 235000018291 probiotics Nutrition 0.000 claims description 11
- 240000004510 Agastache rugosa Species 0.000 claims description 10
- 241000205585 Aquilegia canadensis Species 0.000 claims description 10
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 10
- 244000298479 Cichorium intybus Species 0.000 claims description 10
- 235000001938 Citrus medica Nutrition 0.000 claims description 10
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 claims description 10
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 10
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 10
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 10
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 10
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 10
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 10
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 10
- 240000000171 Crataegus monogyna Species 0.000 claims description 10
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 10
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 10
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 10
- 240000001008 Dimocarpus longan Species 0.000 claims description 10
- 235000000235 Euphoria longan Nutrition 0.000 claims description 10
- 241000287828 Gallus gallus Species 0.000 claims description 10
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 10
- 235000013717 Houttuynia Nutrition 0.000 claims description 10
- 240000000691 Houttuynia cordata Species 0.000 claims description 10
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims description 10
- 240000003582 Platycodon grandiflorus Species 0.000 claims description 10
- 244000197580 Poria cocos Species 0.000 claims description 10
- 235000008599 Poria cocos Nutrition 0.000 claims description 10
- 244000273928 Zingiber officinale Species 0.000 claims description 10
- 210000004317 gizzard Anatomy 0.000 claims description 10
- 235000012907 honey Nutrition 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 10
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 9
- 241000304531 Allium macrostemon Species 0.000 claims description 9
- 244000061520 Angelica archangelica Species 0.000 claims description 9
- 241000522254 Cassia Species 0.000 claims description 9
- 244000111489 Gardenia augusta Species 0.000 claims description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 9
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 claims description 9
- 240000004153 Hibiscus sabdariffa Species 0.000 claims description 9
- 235000013421 Kaempferia galanga Nutrition 0.000 claims description 9
- 244000062241 Kaempferia galanga Species 0.000 claims description 9
- 241000234435 Lilium Species 0.000 claims description 9
- 240000003915 Lophatherum gracile Species 0.000 claims description 9
- 244000270834 Myristica fragrans Species 0.000 claims description 9
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 9
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 9
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 9
- 239000001702 nutmeg Substances 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 9
- 244000144730 Amygdalus persica Species 0.000 claims description 8
- 235000015489 Emblica officinalis Nutrition 0.000 claims description 8
- 235000016641 Syzygium paniculatum Nutrition 0.000 claims description 8
- 244000223082 Syzygium paniculatum Species 0.000 claims description 8
- 239000003292 glue Substances 0.000 claims description 8
- 230000002829 reductive effect Effects 0.000 claims description 8
- 244000119298 Emblica officinalis Species 0.000 claims description 7
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 6
- 244000241838 Lycium barbarum Species 0.000 claims description 6
- 230000000529 probiotic effect Effects 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 235000008184 Piper nigrum Nutrition 0.000 claims description 5
- 244000203593 Piper nigrum Species 0.000 claims description 5
- 240000001949 Taraxacum officinale Species 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 235000013614 black pepper Nutrition 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000000470 constituent Substances 0.000 claims description 4
- 235000005911 diet Nutrition 0.000 claims description 4
- 241001474977 Palla Species 0.000 claims description 3
- 241000271897 Viperidae Species 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 230000037213 diet Effects 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 241000675108 Citrus tangerina Species 0.000 claims description 2
- 239000000022 bacteriostatic agent Substances 0.000 claims description 2
- 229940100688 oral solution Drugs 0.000 claims description 2
- 240000002853 Nelumbo nucifera Species 0.000 claims 4
- 244000088415 Raphanus sativus Species 0.000 claims 2
- 235000002710 Ilex cornuta Nutrition 0.000 claims 1
- 241001310146 Ilex cornuta Species 0.000 claims 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 229940124277 aminobutyric acid Drugs 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 39
- 238000000034 method Methods 0.000 abstract description 38
- 201000010099 disease Diseases 0.000 abstract description 35
- 235000016709 nutrition Nutrition 0.000 abstract description 35
- 230000036541 health Effects 0.000 abstract description 29
- 230000035764 nutrition Effects 0.000 abstract description 21
- 230000036039 immunity Effects 0.000 abstract description 15
- 230000002265 prevention Effects 0.000 abstract description 12
- 238000004891 communication Methods 0.000 abstract description 8
- 235000015097 nutrients Nutrition 0.000 abstract description 6
- 238000001035 drying Methods 0.000 abstract description 3
- 238000009472 formulation Methods 0.000 abstract description 3
- 239000013589 supplement Substances 0.000 abstract description 3
- 241000208340 Araliaceae Species 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 70
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 48
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 45
- 239000003814 drug Substances 0.000 description 43
- 235000019197 fats Nutrition 0.000 description 43
- 210000000952 spleen Anatomy 0.000 description 38
- 210000002784 stomach Anatomy 0.000 description 37
- 235000018102 proteins Nutrition 0.000 description 35
- 102000004169 proteins and genes Human genes 0.000 description 35
- 108090000623 proteins and genes Proteins 0.000 description 35
- 210000004072 lung Anatomy 0.000 description 31
- 206010011224 Cough Diseases 0.000 description 30
- 239000011575 calcium Substances 0.000 description 29
- 229910052791 calcium Inorganic materials 0.000 description 29
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 28
- 206010062717 Increased upper airway secretion Diseases 0.000 description 28
- 235000001465 calcium Nutrition 0.000 description 28
- 208000026435 phlegm Diseases 0.000 description 28
- 235000009508 confectionery Nutrition 0.000 description 27
- 235000013305 food Nutrition 0.000 description 25
- 238000004519 manufacturing process Methods 0.000 description 24
- 239000000047 product Substances 0.000 description 24
- 235000001014 amino acid Nutrition 0.000 description 23
- 229940024606 amino acid Drugs 0.000 description 23
- 229910052742 iron Inorganic materials 0.000 description 23
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 22
- 229930003268 Vitamin C Natural products 0.000 description 22
- 241000724115 Ziziphus lotus Species 0.000 description 22
- 150000001413 amino acids Chemical class 0.000 description 22
- 229960003284 iron Drugs 0.000 description 22
- 229940088594 vitamin Drugs 0.000 description 22
- 229930003231 vitamin Natural products 0.000 description 22
- 235000013343 vitamin Nutrition 0.000 description 22
- 239000011782 vitamin Substances 0.000 description 22
- 235000019154 vitamin C Nutrition 0.000 description 22
- 239000011718 vitamin C Substances 0.000 description 22
- 206010047700 Vomiting Diseases 0.000 description 21
- 206010012735 Diarrhoea Diseases 0.000 description 20
- 239000002253 acid Substances 0.000 description 20
- 230000006870 function Effects 0.000 description 20
- 210000004185 liver Anatomy 0.000 description 20
- 150000003722 vitamin derivatives Chemical class 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 19
- 230000036407 pain Effects 0.000 description 19
- 230000008673 vomiting Effects 0.000 description 18
- 229910052698 phosphorus Inorganic materials 0.000 description 17
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 16
- 239000011574 phosphorus Substances 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 16
- 206010010774 Constipation Diseases 0.000 description 15
- 208000001848 dysentery Diseases 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 230000009286 beneficial effect Effects 0.000 description 13
- 150000001720 carbohydrates Chemical class 0.000 description 13
- 235000014633 carbohydrates Nutrition 0.000 description 13
- 239000000306 component Substances 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 13
- 206010030113 Oedema Diseases 0.000 description 12
- 208000004880 Polyuria Diseases 0.000 description 12
- 244000269722 Thea sinensis Species 0.000 description 12
- 230000035619 diuresis Effects 0.000 description 12
- 238000011160 research Methods 0.000 description 12
- 235000013616 tea Nutrition 0.000 description 12
- 239000011573 trace mineral Substances 0.000 description 12
- 235000013619 trace mineral Nutrition 0.000 description 12
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 11
- 241000220259 Raphanus Species 0.000 description 11
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 11
- 210000001015 abdomen Anatomy 0.000 description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 208000002173 dizziness Diseases 0.000 description 11
- 201000006549 dyspepsia Diseases 0.000 description 11
- 206010000087 Abdominal pain upper Diseases 0.000 description 10
- 206010019233 Headaches Diseases 0.000 description 10
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 10
- 229930003944 flavone Natural products 0.000 description 10
- 235000011949 flavones Nutrition 0.000 description 10
- 229930182478 glucoside Natural products 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 239000011701 zinc Substances 0.000 description 10
- 229910052725 zinc Inorganic materials 0.000 description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 206010033557 Palpitations Diseases 0.000 description 9
- 206010036790 Productive cough Diseases 0.000 description 9
- 208000001431 Psychomotor Agitation Diseases 0.000 description 9
- 206010038743 Restlessness Diseases 0.000 description 9
- 208000006673 asthma Diseases 0.000 description 9
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 9
- 210000000038 chest Anatomy 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 231100000869 headache Toxicity 0.000 description 9
- 210000000936 intestine Anatomy 0.000 description 9
- 230000027939 micturition Effects 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 9
- 229960003495 thiamine Drugs 0.000 description 9
- 239000011691 vitamin B1 Substances 0.000 description 9
- 239000000341 volatile oil Substances 0.000 description 9
- 206010023126 Jaundice Diseases 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- 244000185386 Thladiantha grosvenorii Species 0.000 description 8
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 8
- 208000025865 Ulcer Diseases 0.000 description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 8
- 230000003712 anti-aging effect Effects 0.000 description 8
- 230000003796 beauty Effects 0.000 description 8
- 229910052802 copper Inorganic materials 0.000 description 8
- 239000010949 copper Substances 0.000 description 8
- 150000008131 glucosides Chemical class 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- 229960003512 nicotinic acid Drugs 0.000 description 8
- 235000001968 nicotinic acid Nutrition 0.000 description 8
- 239000011664 nicotinic acid Substances 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 229920001282 polysaccharide Polymers 0.000 description 8
- 239000005017 polysaccharide Substances 0.000 description 8
- 229910052700 potassium Inorganic materials 0.000 description 8
- 230000035922 thirst Effects 0.000 description 8
- 231100000397 ulcer Toxicity 0.000 description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 7
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 7
- 229920002307 Dextran Polymers 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- 244000235659 Rubus idaeus Species 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 7
- 241000245665 Taraxacum Species 0.000 description 7
- 229930003451 Vitamin B1 Natural products 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 230000004087 circulation Effects 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 150000004676 glycans Chemical class 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 235000007686 potassium Nutrition 0.000 description 7
- 229960002477 riboflavin Drugs 0.000 description 7
- 229910052711 selenium Inorganic materials 0.000 description 7
- 239000011669 selenium Substances 0.000 description 7
- 235000010374 vitamin B1 Nutrition 0.000 description 7
- 235000011511 Diospyros Nutrition 0.000 description 6
- 244000236655 Diospyros kaki Species 0.000 description 6
- 235000003333 Diospyros lotus Nutrition 0.000 description 6
- 244000022372 Diospyros lotus Species 0.000 description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 206010046788 Uterine haemorrhage Diseases 0.000 description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 6
- 241000234314 Zingiber Species 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 6
- 229930013930 alkaloid Natural products 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 210000004209 hair Anatomy 0.000 description 6
- 229910001385 heavy metal Inorganic materials 0.000 description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 6
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 235000001055 magnesium Nutrition 0.000 description 6
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 6
- 235000008935 nutritious Nutrition 0.000 description 6
- 235000005875 quercetin Nutrition 0.000 description 6
- 210000003802 sputum Anatomy 0.000 description 6
- 208000024794 sputum Diseases 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 235000018553 tannin Nutrition 0.000 description 6
- 229920001864 tannin Polymers 0.000 description 6
- 239000001648 tannin Substances 0.000 description 6
- 235000019155 vitamin A Nutrition 0.000 description 6
- 239000011719 vitamin A Substances 0.000 description 6
- 229940045997 vitamin a Drugs 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 150000003797 alkaloid derivatives Chemical class 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 208000034158 bleeding Diseases 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 239000007910 chewable tablet Substances 0.000 description 5
- 235000013325 dietary fiber Nutrition 0.000 description 5
- 150000002213 flavones Chemical class 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 208000035861 hematochezia Diseases 0.000 description 5
- 208000014617 hemorrhoid Diseases 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 230000000050 nutritive effect Effects 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 206010036067 polydipsia Diseases 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 239000011716 vitamin B2 Substances 0.000 description 5
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 4
- 235000017491 Bambusa tulda Nutrition 0.000 description 4
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 206010018612 Gonorrhoea Diseases 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 4
- 239000005913 Maltodextrin Substances 0.000 description 4
- 229920002774 Maltodextrin Polymers 0.000 description 4
- 244000082204 Phyllostachys viridis Species 0.000 description 4
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229930182558 Sterol Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 239000005864 Sulphur Substances 0.000 description 4
- 229930003471 Vitamin B2 Natural products 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000011425 bamboo Substances 0.000 description 4
- 235000021028 berry Nutrition 0.000 description 4
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 4
- NDVASEGYNIMXJL-UHFFFAOYSA-N beta-sabinene Natural products C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 206010006451 bronchitis Diseases 0.000 description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 108010084210 citrin Proteins 0.000 description 4
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 235000020778 linoleic acid Nutrition 0.000 description 4
- 229960004232 linoleic acid Drugs 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229940035034 maltodextrin Drugs 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 4
- 239000001814 pectin Substances 0.000 description 4
- 229920001277 pectin Polymers 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 230000004224 protection Effects 0.000 description 4
- 229960001285 quercetin Drugs 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- HUJXHFRXWWGYQH-UHFFFAOYSA-O sinapine Chemical compound COC1=CC(\C=C\C(=O)OCC[N+](C)(C)C)=CC(OC)=C1O HUJXHFRXWWGYQH-UHFFFAOYSA-O 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- 150000003432 sterols Chemical class 0.000 description 4
- 235000003702 sterols Nutrition 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- 201000004647 tinea pedis Diseases 0.000 description 4
- 235000019164 vitamin B2 Nutrition 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- OGLDWXZKYODSOB-UHFFFAOYSA-N α-phellandrene Chemical compound CC(C)C1CC=C(C)C=C1 OGLDWXZKYODSOB-UHFFFAOYSA-N 0.000 description 4
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 description 4
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 3
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 240000001548 Camellia japonica Species 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- 240000005250 Chrysanthemum indicum Species 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 235000021360 Myristic acid Nutrition 0.000 description 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- 240000005809 Prunus persica Species 0.000 description 3
- 206010044302 Tracheitis Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 229930006722 beta-pinene Natural products 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 235000018597 common camellia Nutrition 0.000 description 3
- 235000001671 coumarin Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 208000033065 inborn errors of immunity Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 201000005630 leukorrhea Diseases 0.000 description 3
- 235000001510 limonene Nutrition 0.000 description 3
- 229940087305 limonene Drugs 0.000 description 3
- 229930007744 linalool Natural products 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 235000018977 lysine Nutrition 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 229940099690 malic acid Drugs 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 3
- 235000013930 proline Nutrition 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 235000019192 riboflavin Nutrition 0.000 description 3
- 239000002151 riboflavin Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 206010046901 vaginal discharge Diseases 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 235000014101 wine Nutrition 0.000 description 3
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 3
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- WUYQEGNOQLRQAQ-CQSZACIVSA-N (+)-pronuciferine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-CQSZACIVSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- APTNOIWSCDBIAS-UHFFFAOYSA-N 5,10,11-trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C1C(O)C(O)C(CO)(CO)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C APTNOIWSCDBIAS-UHFFFAOYSA-N 0.000 description 2
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 2
- MQBFFYQCZCKSBX-UHFFFAOYSA-N 5-hydroxy-6,7,8-trimethoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=C(OC)C(OC)=C(OC)C(O)=C3C(=O)C=2)=C1 MQBFFYQCZCKSBX-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 244000298715 Actinidia chinensis Species 0.000 description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 241000132012 Atractylodes Species 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 241001264174 Cordyceps militaris Species 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000026010 Dendrobium candidum Species 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 208000032928 Dyslipidaemia Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 2
- 240000008397 Ganoderma lucidum Species 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 2
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 208000025844 Prostatic disease Diseases 0.000 description 2
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 2
- 235000010586 Sophora japonica Nutrition 0.000 description 2
- 244000046101 Sophora japonica Species 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 206010001093 acute tonsillitis Diseases 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 201000007930 alcohol dependence Diseases 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- OGLDWXZKYODSOB-SNVBAGLBSA-N alpha-phellandrene Natural products CC(C)[C@H]1CC=C(C)C=C1 OGLDWXZKYODSOB-SNVBAGLBSA-N 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 238000013475 authorization Methods 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000006189 buccal tablet Substances 0.000 description 2
- 229940046011 buccal tablet Drugs 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 239000000292 calcium oxide Substances 0.000 description 2
- 235000012255 calcium oxide Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 210000004413 cardiac myocyte Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 230000002279 cholagogic effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 229930003633 citronellal Natural products 0.000 description 2
- 235000000983 citronellal Nutrition 0.000 description 2
- KZJWDPNRJALLNS-FBZNIEFRSA-N clionasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-FBZNIEFRSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000004775 coumarins Chemical class 0.000 description 2
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000007919 dispersible tablet Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- FPVGTPBMTFTMRT-NSKUCRDLSA-L fast yellow Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 FPVGTPBMTFTMRT-NSKUCRDLSA-L 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- VCCRNZQBSJXYJD-UHFFFAOYSA-N galangin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=CC=C1 VCCRNZQBSJXYJD-UHFFFAOYSA-N 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 208000018706 hematopoietic system disease Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- SQFSKOYWJBQGKQ-UHFFFAOYSA-N kaempferide Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 SQFSKOYWJBQGKQ-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 235000005772 leucine Nutrition 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- BNWJOHGLIBDBOB-UHFFFAOYSA-N myristicin Chemical compound COC1=CC(CC=C)=CC2=C1OCO2 BNWJOHGLIBDBOB-UHFFFAOYSA-N 0.000 description 2
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 2
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 229960003684 oxedrine Drugs 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 2
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 229940023488 pill Drugs 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 235000021013 raspberries Nutrition 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- ULSUXBXHSYSGDT-UHFFFAOYSA-N tangeretin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 ULSUXBXHSYSGDT-UHFFFAOYSA-N 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 230000008542 thermal sensitivity Effects 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 2
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- WUYQEGNOQLRQAQ-UHFFFAOYSA-N (+)-pronuciferine Natural products C1=2C3=C(OC)C(OC)=CC=2CCN(C)C1CC13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-UHFFFAOYSA-N 0.000 description 1
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- VZTUKBKUWSHDFM-CYBMUJFWSA-N (-)-annonaine Chemical compound C1C2=CC=CC=C2C2=C(OCO3)C3=CC3=C2[C@@H]1NCC3 VZTUKBKUWSHDFM-CYBMUJFWSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- FFDULTAFAQRACT-NYYYOYJKSA-N (-)-syringaresinol O,O'-bis(beta-D-glucoside) Chemical compound COC1=CC([C@H]2[C@H]3[C@H]([C@@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-NYYYOYJKSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- UFLHIIWVXFIJGU-ONEGZZNKSA-N (E)-hex-3-en-1-ol Chemical compound CC\C=C\CCO UFLHIIWVXFIJGU-ONEGZZNKSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- ZKSZEJFBGODIJW-GMDXDWKASA-N (R)-prunasin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H](C#N)C1=CC=CC=C1 ZKSZEJFBGODIJW-GMDXDWKASA-N 0.000 description 1
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- YZAZXIUFBCPZGB-QZOPMXJLSA-N (z)-octadec-9-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O YZAZXIUFBCPZGB-QZOPMXJLSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 125000002006 1,8-cineol group Chemical group 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- BDHQMRXFDYJGII-UEBIAWITSA-N 24-methylenecycloartanol Chemical compound CC(C)([C@@H](O)CC1)[C@H]2[C@@]31C[C@@]13CC[C@]3(C)[C@@H]([C@H](C)CCC(=C)C(C)C)CC[C@@]3(C)[C@@H]1CC2 BDHQMRXFDYJGII-UEBIAWITSA-N 0.000 description 1
- KKSCKZFKHNHGEO-UHFFFAOYSA-N 24-methylenecycloartanol Natural products CC(CCC(=C)C(C)(C)O)C1CCC2C3CCC4C(C)(C)C(O)CCC45CC35CCC12C KKSCKZFKHNHGEO-UHFFFAOYSA-N 0.000 description 1
- BJZVHTWNCLKZGN-SPQNPFHSSA-N 24-methylidenecycloartanol Natural products CC(C)C(=C)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C(C)(C)[C@@H](O)CC[C@@]45C[C@@]35CC[C@]12C BJZVHTWNCLKZGN-SPQNPFHSSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- HRGUSFBJBOKSML-UHFFFAOYSA-N 3',5'-di-O-methyltricetin Chemical compound COC1=C(O)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 HRGUSFBJBOKSML-UHFFFAOYSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- CWVRJTMFETXNAD-GMZLATJGSA-N 5-Caffeoyl quinic acid Natural products O[C@H]1C[C@](O)(C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-GMZLATJGSA-N 0.000 description 1
- TUGAUFMQYWZJAB-FPLPWBNLSA-N 5-[(8Z)-pentadec-8-enyl]resorcinol Chemical compound CCCCCC\C=C/CCCCCCCC1=CC(O)=CC(O)=C1 TUGAUFMQYWZJAB-FPLPWBNLSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 244000141331 Amomum villosum Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- BRYYLWHNGJJMQM-UHFFFAOYSA-N Anonaine Natural products C1OC2=CC3=CCNC4=C3C(=C2O1)C5=CC=CCC5C4 BRYYLWHNGJJMQM-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- ZBKFZIUKXTWQTP-QGZVFWFLSA-N Armepavine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 ZBKFZIUKXTWQTP-QGZVFWFLSA-N 0.000 description 1
- ZBKFZIUKXTWQTP-KRWDZBQOSA-N Armepavine Natural products C([C@@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 ZBKFZIUKXTWQTP-KRWDZBQOSA-N 0.000 description 1
- 206010003402 Arthropod sting Diseases 0.000 description 1
- NWUMSRKLBRWRAS-UHFFFAOYSA-N Arundoin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1(C)C NWUMSRKLBRWRAS-UHFFFAOYSA-N 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- SRLTUZDQBFYLQI-FPLPWBNLSA-N Bilobol Natural products Oc1c(CCCCCCC/C=C\CCCCCC)ccc(O)c1 SRLTUZDQBFYLQI-FPLPWBNLSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 208000003014 Bites and Stings Diseases 0.000 description 1
- 235000011371 Brassica hirta Nutrition 0.000 description 1
- 244000140786 Brassica hirta Species 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 241000282985 Cervus Species 0.000 description 1
- 241000283007 Cervus nippon Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000193171 Clostridium butyricum Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 241000209205 Coix Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- MRNPHCMRIQYRFU-UWAWSDATSA-N Cylindrin Chemical compound C([C@@]1(C)[C@H](C(C)C)CC[C@@H]1[C@@]1(C)CC=C23)C[C@@]1(C)[C@@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-UWAWSDATSA-N 0.000 description 1
- BRQBMPGDACUHNR-UHFFFAOYSA-N Cylindrin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CCC(C(C)C)C5CCC34C)C1(C)C BRQBMPGDACUHNR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- CBOKHFLBNZMMAA-UHFFFAOYSA-N Emodin anthrone Natural products OC1=CC(O)=CC2=CC3=CC(C)=CC(O)=C3C(O)=C21 CBOKHFLBNZMMAA-UHFFFAOYSA-N 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241001465251 Ephedra sinica Species 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- VWYANPOOORUCFJ-YHEBVWOXSA-N Fernenol Chemical compound CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@@]4(C)[C@@H]5CC[C@H](C(C)C)[C@@]5(C)CC[C@]4(C)[C@H]3CC[C@H]21 VWYANPOOORUCFJ-YHEBVWOXSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical group O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 229930188400 Gardenin Natural products 0.000 description 1
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- ZJDOESGVOWAULF-OGJQONSISA-N Geniposidic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=CC[C@@H]2C(C(O)=O)=CO1 ZJDOESGVOWAULF-OGJQONSISA-N 0.000 description 1
- VYAALAFRWREWLA-BVTMAQQCSA-N Geniposidic acid Natural products CCC1=CC[C@H]2[C@@H]1[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C2C(=O)O VYAALAFRWREWLA-BVTMAQQCSA-N 0.000 description 1
- ZJDOESGVOWAULF-UHFFFAOYSA-N Geniposidinsaeure Natural products OC1C(O)C(O)C(CO)OC1OC1C2C(CO)=CCC2C(C(O)=O)=CO1 ZJDOESGVOWAULF-UHFFFAOYSA-N 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- FEUWBELGELLWPV-UHFFFAOYSA-N Glycerol sinapate Natural products COC1=C(O)C(OC)=CC(C=CC(=O)OCC(COC(=O)C=CC=2C=C(OC)C(O)=C(OC)C=2)OC(=O)C=CC=2C=C(OC)C(O)=C(OC)C=2)=C1 FEUWBELGELLWPV-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- TWVJWDMOZJXUID-SDDRHHMPSA-N Guaiol Chemical compound C1([C@H](CC[C@H](C2)C(C)(C)O)C)=C2[C@@H](C)CC1 TWVJWDMOZJXUID-SDDRHHMPSA-N 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 235000008755 Lupinus mutabilis Nutrition 0.000 description 1
- 240000005265 Lupinus mutabilis Species 0.000 description 1
- 208000018501 Lymphatic disease Diseases 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 241000207960 Pedaliaceae Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000229722 Perilla <angiosperm> Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropyl alcohol Natural products CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241001130943 Phyllanthus <Aves> Species 0.000 description 1
- 240000009120 Phyllanthus emblica Species 0.000 description 1
- IDDMFNIRSJVBHE-UHFFFAOYSA-N Piscigenin Natural products COC1=C(O)C(OC)=CC(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)=C1 IDDMFNIRSJVBHE-UHFFFAOYSA-N 0.000 description 1
- HFNGSIBHHMFWQB-UHFFFAOYSA-N Platycogenic acid A Natural products C1C(O)C(O)C(CO)(C(O)=O)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C HFNGSIBHHMFWQB-UHFFFAOYSA-N 0.000 description 1
- DGNAEYFEAUVDAJ-UHFFFAOYSA-N Platycogenic acid B Natural products CC12CC(O)C(O)C(C)(C(O)=O)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)CC3(C(O)=O)C(O)CC21C DGNAEYFEAUVDAJ-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- VZRKWGPIZJDNHC-UHFFFAOYSA-N Polygalic acid Natural products CC1(C)CCC2(CCC3=C(CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(O)=O)C2C1)C(O)=O VZRKWGPIZJDNHC-UHFFFAOYSA-N 0.000 description 1
- VZRKWGPIZJDNHC-LUNVCWBOSA-N Polygalic acid Polymers CC1(C)CC[C@@]2(CCC3=C(CC[C@@H]4[C@@]5(C)C[C@H](O)[C@H](O)[C@](C)([C@@H]5CC[C@@]34C)C(O)=O)[C@@H]2C1)C(O)=O VZRKWGPIZJDNHC-LUNVCWBOSA-N 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 241000123889 Rubus chingii Species 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- BZPMXJKRKXDRID-UOIKKKDVSA-N Scandoside Natural products OC[C@H]1O[C@@H](O[C@H]2CC=C([C@@H]3[C@@H](O)C=C(CO)[C@H]23)C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O BZPMXJKRKXDRID-UOIKKKDVSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 235000019095 Sechium edule Nutrition 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- XVXPXUMUGATHPD-JMJRLLIOSA-N Simiarenol Chemical compound C([C@@H]1[C@@]2(C)CC[C@@]3(C)[C@H]([C@@]2(CC[C@]11C)C)CC[C@@H]3C(C)C)C=C2[C@H]1CC[C@H](O)C2(C)C XVXPXUMUGATHPD-JMJRLLIOSA-N 0.000 description 1
- XVXPXUMUGATHPD-UHFFFAOYSA-N Simiarol Natural products CC(C)C1CCC(C2(CCC34C)C)C1(C)CCC2(C)C3CC=C1C4CCC(O)C1(C)C XVXPXUMUGATHPD-UHFFFAOYSA-N 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- QKGJFQMGPDVOQE-UHFFFAOYSA-N Sulforaphen Natural products CS(=O)C=CCCN=C=S QKGJFQMGPDVOQE-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- IECRXMSGDFIOEY-UHFFFAOYSA-N Tangeretin Natural products COC=1C(OC)=C(OC)C(OC)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 IECRXMSGDFIOEY-UHFFFAOYSA-N 0.000 description 1
- 241001627955 Tetraodon lineatus Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 235000016410 Torreya grandis Nutrition 0.000 description 1
- 240000000147 Torreya grandis Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- CLBZPEGXXFEYIP-UHFFFAOYSA-L [O-2].[Fe+4].C([O-])([O-])=O Chemical compound [O-2].[Fe+4].C([O-])([O-])=O CLBZPEGXXFEYIP-UHFFFAOYSA-L 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- 125000001839 alpha-thujene group Chemical group 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002927 anti-mitotic effect Effects 0.000 description 1
- 230000001062 anti-nausea Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000002223 anti-pathogen Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 231100001015 blood dyscrasias Toxicity 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- OKTJSMMVPCPJKN-YPZZEJLDSA-N carbon-10 atom Chemical compound [10C] OKTJSMMVPCPJKN-YPZZEJLDSA-N 0.000 description 1
- 125000005588 carbonic acid salt group Chemical group 0.000 description 1
- KEVIIPRPZFKDMS-UHFFFAOYSA-N carbonic acid;octadecanoic acid Chemical compound OC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O KEVIIPRPZFKDMS-UHFFFAOYSA-N 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 229940107218 chromium Drugs 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- DKZBBWMURDFHNE-NSCUHMNNSA-N coniferyl aldehyde Chemical compound COC1=CC(\C=C\C=O)=CC=C1O DKZBBWMURDFHNE-NSCUHMNNSA-N 0.000 description 1
- 238000004320 controlled atmosphere Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 108010089310 cylindrin Proteins 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- DIOQZVSQGTUSAI-NJFSPNSNSA-N decane Chemical compound CCCCCCCCC[14CH3] DIOQZVSQGTUSAI-NJFSPNSNSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- JYIMWRSJCRRYNK-UHFFFAOYSA-N dialuminum;disodium;oxygen(2-);silicon(4+);hydrate Chemical compound O.[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Al+3].[Al+3].[Si+4] JYIMWRSJCRRYNK-UHFFFAOYSA-N 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- VFNGKCDDZUSWLR-UHFFFAOYSA-L disulfate(2-) Chemical compound [O-]S(=O)(=O)OS([O-])(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-L 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000015177 dried meat Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- LAJSXCAVRQXZIO-UHFFFAOYSA-N emodin anthrone Chemical compound C1=C(O)C=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O LAJSXCAVRQXZIO-UHFFFAOYSA-N 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- CIPSYTVGZURWPT-UHFFFAOYSA-N galangin Natural products OC1=C(Oc2cc(O)c(O)cc2C1=O)c3ccccc3 CIPSYTVGZURWPT-UHFFFAOYSA-N 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-STIDJNKJSA-N gamma-sitosterol Natural products CC[C@@H](CC[C@@H](C)[C@@H]1CC[C@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C KZJWDPNRJALLNS-STIDJNKJSA-N 0.000 description 1
- 208000027692 gas pain Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- XOXYHGOIRWABTC-UHFFFAOYSA-N gentisin Chemical compound C1=C(O)C=C2C(=O)C3=C(O)C=C(OC)C=C3OC2=C1 XOXYHGOIRWABTC-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- TWVJWDMOZJXUID-QJPTWQEYSA-N guaiol Natural products OC(C)(C)[C@H]1CC=2[C@H](C)CCC=2[C@@H](C)CC1 TWVJWDMOZJXUID-QJPTWQEYSA-N 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- KYYWBEYKBLQSFW-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O KYYWBEYKBLQSFW-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- USOSNFWVEWONDB-UHFFFAOYSA-N liriodendrin Natural products COc1cc(cc(OC)c1OC2OC(CO)C(O)C(O)C2O)C3OC(C)(C)C4C(OC(C)(C)C34)c5cc(OC)c(OC6OC(CO)C(O)C(O)C6O)c(OC)c5 USOSNFWVEWONDB-UHFFFAOYSA-N 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 208000018555 lymphatic system disease Diseases 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 210000000537 nasal bone Anatomy 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- ZKSZEJFBGODIJW-UHFFFAOYSA-N passiedulin Natural products OC1C(O)C(O)C(CO)OC1OC(C#N)C1=CC=CC=C1 ZKSZEJFBGODIJW-UHFFFAOYSA-N 0.000 description 1
- 229940112824 paste Drugs 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- SUYJZKRQHBQNCA-UHFFFAOYSA-N pinobanksin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=CC=C1 SUYJZKRQHBQNCA-UHFFFAOYSA-N 0.000 description 1
- 235000019617 piquancy Nutrition 0.000 description 1
- XTDAUCLSJYHNGJ-UHFFFAOYSA-N platycogenic acid C Natural products CC12CC(O)C(O)C(C)(C)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)CC3(C(O)=O)C(O)CC21C XTDAUCLSJYHNGJ-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229930001545 pronuciferine Natural products 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- BMXNUTUYWQWEFA-UHFFFAOYSA-N prunasin Natural products OCC1OC(O)C(O)C(O)C1OC(C#N)c2ccccc2 BMXNUTUYWQWEFA-UHFFFAOYSA-N 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- QKGJFQMGPDVOQE-HWKANZROSA-N raphanin Chemical compound CS(=O)\C=C\CCN=C=S QKGJFQMGPDVOQE-HWKANZROSA-N 0.000 description 1
- 239000010499 rapseed oil Substances 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- USDOQCCMRDNVAH-UHFFFAOYSA-N sigma-cadinene Natural products C1C=C(C)CC2C(C(C)C)CC=C(C)C21 USDOQCCMRDNVAH-UHFFFAOYSA-N 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- KYSWLLSZOWOOGF-UHFFFAOYSA-N sorghumol Natural products O1C(=O)C(C)=CC1OC=C1C(=O)OC2C(C(C)(CO)CCC3)=C3CC21 KYSWLLSZOWOOGF-UHFFFAOYSA-N 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000000053 special nutrition Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- GHIZCSMTYWOBQA-BZSCQJQFSA-N spinasterol Natural products CC[C@H](C=C[C@@H](C)[C@@H]1CC[C@@]2(C)C3=CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C GHIZCSMTYWOBQA-BZSCQJQFSA-N 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 1
- COBXDAOIDYGHGK-UHFFFAOYSA-N syringaldehyde Natural products COC1=CC=C(C=O)C(OC)=C1O COBXDAOIDYGHGK-UHFFFAOYSA-N 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 108010050939 thrombocytin Proteins 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- DKZBBWMURDFHNE-UHFFFAOYSA-N trans-coniferylaldehyde Natural products COC1=CC(C=CC=O)=CC=C1O DKZBBWMURDFHNE-UHFFFAOYSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- BMCJATLPEJCACU-UHFFFAOYSA-N tricin Natural products COc1cc(OC)c(O)c(c1)C2=CC(=O)c3c(O)cc(O)cc3O2 BMCJATLPEJCACU-UHFFFAOYSA-N 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- USDOQCCMRDNVAH-KKUMJFAQSA-N β-cadinene Chemical compound C1C=C(C)C[C@H]2[C@H](C(C)C)CC=C(C)[C@@H]21 USDOQCCMRDNVAH-KKUMJFAQSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种含蜂花粉的膳食营养补充剂,主要包括以下质量份数的原料:蜂花粉1‑15份,人参1‑5份,黄精1‑10份、复合氨基酸粉1‑10份,牛磺酸1‑10份,还可以添加药学上可接受的原料和辅料制成各种剂型。结合真空冷冻干燥技术、气流超微粉碎技术、微粉包合技术三大技术并通过蜂花粉科学配伍人参、黄精等原料,保证了本发明膳食营养补充剂能够充分保留原料的营养和活性成分,均衡补充营养,全面提升免疫力,预防疾病和亚健康。
Description
技术领域
本发明涉及一种膳食营养补充剂及其制备方法,具体说是一种含蜂花粉的膳食营养补充剂及其制备方法。
背景技术
中药材超微粉碎技术是在近代工业技术与中医药结合基础上发展起来的“民生科技”。已有研究表明:超微粉碎技术在中医药领域中的应用,不仅具有“资源节约型,环境友好型”特色,而且有改善中药加工性能;提高中药制剂的均匀性,改善中药制剂的批间稳定性,从而确保中成药批间疗效的一致性;加快中药活性成分的溶出,提高溶出率,使吸收速度和程度增大,从而提高中药制剂的效应强度和起效速度,打破长期以来“中药起效慢,作用强度低”的思维定势;减少用药剂量,节约原料药材,有利于缓解中药材紧张,尤其是濒危中药材资源紧张的局面,有利于中医药的持续发展等优势。
目前常用的超微粉碎方式主要有高频振动式、机械式和气流式三种类型。
高频振动式超微粉碎主要是磨介式粉碎,比如振动磨,其工作原理是:用弹簧支撑机体,由带有偏心块的主轴使其振动,运转时通过介质和物料一起振动粉碎研磨物料。由于是高频振动和摩擦,容易产生局部高温,使部分活性成分失活。同时,高强度的摩擦也极易将机械设备中的重金属带入到中药材中,使重金属含量超标。
机械式超微粉碎机比较常见,有齿式粉碎机、锤式粉碎机、刀式粉碎机、涡轮式粉碎机等,其工作原理是:通过机械零件和介质的高速运动对原药材粉体施加冲击、剪切等外力达到粉碎目的。与高频振动式超微粉碎一样,机械式超微粉碎设备也易升温,同时物料粉碎得越细零件磨损越严重,磨损微粒直接污染物料。
气流式超微粉碎工作原理是:超音速气流使物料粒子相互激烈碰撞、摩擦,且气流对物料有直接的剪切作用,再通过适当分级达到粉碎的目的。气流式超微粉碎具有如下特点:
(1)粉体粉碎率高,几乎无损耗;
(2)粉体的粉碎在低温下瞬间完成,避免了某种物质在粉碎过程中产生热量而破坏其性能的现象发生;
(3)磨介采用特殊材料制成,最大程度地减轻零部件磨损,几乎无重金属残留和不溶性异物,保证用药安全;
(4)完全按照制药GMP的要求,全封闭负压作业,粉体在粉碎过程中不发生任何泄漏,无环境污染,噪声小。
虽然气流式超微粉碎在中药制药中具有如此优势,但是制剂往往不是单纯地超微粉碎,而且由一系列加工工序组合而来,超微粉碎作为其中一道工序虽然能起到作用,但是其它工序亦不能忽视,否则终产品也将达不到质量要求,尤其是膳食营养补充剂类产品,含有维生素、活性蛋白,对整个生产体系中温度的要求很严格。
发明专利[授权公告号:CN104324109B]提供了一种巴戟肉纯粉超微饮片及其制备方法,通过先真空冷冻干燥,再超微粉碎的方式获得超微纯粉,其中真空冷冻干燥的温度为80~110℃,此冻干温度仅顾及冻干过程,但这么高的温度会破坏原药材的营养成分和活性成分。
发明专利[申请号:CN103652868 A]提供了一种气流超微粉碎技术制备连心超微粉的方法,该方法能意识到随着超微粉体比表面积增加,表面能会使粒子表面更容易吸附坏境中的水分和电荷,超微粉会变得易聚集,流动性、分散性变差,粉末处于非稳定状态,这是制约超微粉碎技术在中药中应用得一大障碍,所以引入了抗结剂硅铝酸钠、二氧化硅、磷酸三钙,不仅使生产工艺更复杂,而且引入的抗结剂使超微粉纯度降低,从原有的纯粉变成了混合物,不利于后续的制剂加工。
发明专利[授权公告号:CN103932185 B]提供了一种铁皮石斛、蛹虫草、灵芝和茶叶的复方咀嚼片及制备方法,将铁皮石斛、蛹虫草、灵芝和茶叶经适当干燥后进行超微粉碎,将所得超微粉碎物料按比例混合,加入甜味剂和润滑剂,经制湿粒、干燥、整粒和压片等工艺制成咀嚼片成品,并声称“最大程度保留了原料中各种生物活性物质,利用率高”。虽然此发明专利应用到了超微粉碎技术,但是只是引入了概念,在其整个生产工艺体系中并没有做到“最大程度保留了原料中各种生物活性物质”。
综上所述,在中药应用方面,尤其在膳食营养补充剂领域,超微粉碎技术虽然得到了一定的推广和应用,但是没有从生产工艺的整体性出发,没有考虑到生产的连续性,没有做到“最大程度保留了原料中各种生物活性物质”,没有充分地将原料中的营养转化到产品中,造成了营养和活性成分的流失和浪费。
发明内容
目的:为了克服现有技术中存在的不足,本发明提供一种含蜂花粉的膳食营养补充剂,能达到充分保留原料的营养和活性成分,全面增强人体免疫力,预防疾病和亚健康。
技术方案:为解决上述技术问题,本发明采用的技术方案为:
一种含蜂花粉的膳食营养补充剂,其特征在于,包括以下质量份数的原料:蜂花粉1-15份,人参1-5份,黄精1-10份、复合氨基酸粉1-10份、牛磺酸1-10份。
作为更优选,还可以包括鹿胶1-5份、鹿血1-5份、龙眼肉1-8份、佛手1-6份、香薷1-9份、桔红1-5份、胖大海1-5份、香橼1-8份、莱菔子1-6份、黄芥子1-8份、紫苏子1-6份、橘皮1-6份、昆布1-6份、山楂1-8份、决明子1-7份、阿萨伊果1-8份、诺丽果浆1-6份、杜仲雄花1-6份、薏苡仁1-6份、酵母-β提取物0.1-0.5、γ-氨基丁酸0.01-0.1份、益生菌粉0.01-0.5份,甘草1-5份、白芷1-5份、白果1-5份、白扁豆1-5份、百合1-5份、肉豆蔻1-5份、肉桂1-5份、余甘子1-5份、杏仁(甜、苦)1-5份、沙棘1-5份、牡蛎1-5份、芡实1-5份、赤小豆1-5份、阿胶1-5份、鸡内金1-5份、麦芽1-5份、昆布1-5份、枣(大枣、酸枣、黑枣)1-5份、罗汉果1-5份、郁李仁1-5份、金银花1-5份、青果1-5份、鱼腥草1-5份、姜(生姜、干姜)1-5份、枳椇子1-5份、枸杞子1-5份、栀子1-5份、砂仁1-5份、胖大海1-5份、茯苓1-5份、香薷1-5份、桃仁1-5份、桑叶1-5份、桑椹1-5份、桔红1-5份、桔梗1-5份、益智仁1-5份、荷叶1-5份、莱菔子1-5份、莲子1-5份、高良姜1-5份、淡竹叶1-5份、淡豆豉1-5份、菊花1-5份、菊苣1-5份、黄芥子1-5份、黄精1-5份、紫苏1-5份、紫苏籽1-5份、葛根1-5份、黑芝麻1-5份、黑胡椒1-5份、槐米1-5份、槐花1-5份、蒲公英1-5份、蜂蜜1-5份、榧子1-5份、酸枣仁1-5份、鲜白茅根1-5份、鲜芦根1-5份、橘皮1-5份、薄荷1-5份、薤白1-5份、覆盆子1-5份、藿香1-5份、玫瑰茄1-5份中的一种或几种或全部。
所述膳食营养补充剂的制备工艺流程:原料预处理→真空冷冻干燥→气流超微粉碎→微粉包合→制剂。
所述蜂花粉选自符合<GB/T 30359 蜂花粉>质量要求的花粉,真空冷冻干燥,使其含水量≤5%,再经粉碎机气流超微粉碎,使其目数>400目,备用。
原料处理方法:鹿胶、鹿血、人参(人工种植)、黄精、龙眼肉、佛手、香薷、桔红、胖大海、香橼、莱菔子、黄芥子、紫苏子、橘皮、昆布、山楂、决明子、阿萨伊果、诺丽果浆、杜仲雄花、薏苡仁、甘草、白芷、白果、白扁豆、百合、肉豆蔻、肉桂、余甘子、杏仁(甜、苦)、沙棘、牡蛎、芡实、赤小豆、阿胶、鸡内金、麦芽、枣(大枣、酸枣、黑枣)、罗汉果、郁李仁、金银花、青果、鱼腥草、姜(生姜、干姜)、枳椇子、枸杞子、栀子、砂仁、茯苓、香薷、桃仁、桑叶、桑椹、桔红、桔梗、益智仁、荷叶、莲子、高良姜、淡竹叶、淡豆豉、菊花、菊苣、黄芥子、黄精、紫苏、葛根、黑芝麻、槐米、槐花、蒲公英、蜂蜜、榧子、酸枣仁、鲜白茅根、鲜芦根、橘皮、薄荷、薤白、覆盆子、藿香、玫瑰茄分别进行预处理,真空冷冻干燥,使其含水量≤5%,再粉碎机经气流超微粉碎,使其颗粒目数>400目,或直接经水(醇)提取得到提取物,备用。
所述酵母-β提取物、γ-氨基丁酸、复合氨基酸粉、牛磺酸要符合相应的国家标准,益生菌活性在1×1010cfu/g以上。
真空冷冻干燥,制冷温度要≤-50℃~-60℃,真空度最大至80pa~100pa,冻干后水分≤5%。①常温或高温下干燥,会造成花粉营养成分的损耗和流失,降低花粉的利用率和生物利用度。②在低温冻干过程中,细胞内的水分形成冰晶,导致细胞膜破裂,真空冷冻干燥的温度愈低,这种破裂的程度愈大,破壁效果更明显,但这对设备要求更高,生产投入更多。所以制冷温度控制在≤-50℃~-60℃,且真空度最大至80pa~100pa,不仅能达到细胞膜破裂的效果,还能节约成本,便于投入生产。③真空冷冻干燥过程中,蜂花粉的水分由液态迅速变为固态,体积变大、膨胀,再加上冰晶使细胞膜破裂,水分升华的过程中,就促使细胞壁破裂,达到破壁的效果。因此,控制好真空冷冻干燥过程,不仅能够降低水分含量,还能有一定的破壁效果。
进一步地,上述生产工艺和原料处理过程中涉及到的气流超微粉碎,颗粒目数>400目。①之所以优选气流式超微粉碎,是因为气流式超微粉碎不会在粉碎过程中导致局部温度过高而破坏蜂花粉的活性,也不会引入重金属而使重金属超标。②气流超微粉碎是在气流作用下,使物料高速相互碰撞而达到破壁的效果,而且粒径分布均匀,便于制剂和进一步生产加工。当颗粒目数>400时,基本可以保证其100%破壁,既节约成分,又便于生产。
进一步地,上述生产工艺中涉及到的微粉包合,并不是通过加入麦芽糊精的包埋技术,也不是用高分子材料做成的发挥缓释作用的微囊包被技术。①微粉包合技术中所述的“微粉”为超微粉碎后的粉体,该粉体不仅会产生静电吸附成团状,而且水冲服时极易成团,通过不引入外来物质改变原有粉体成分构成的前提下,通过“唤醒”粉体自身物质的粘性,将微粉包合成80~100目的颗粒,即本发明中的微粉包合技术。②微粉包合的另外一大优势在于能够增大粉体在体内的利用率。超微粉体粒径太小且吸附性强,在胃中很容易被包裹在其它食物中而代谢掉,没有充分被人体吸收,利用率低,而微粉包合后的颗粒,不会被其他食物包裹,能够参与人体新陈代谢,利用度高。
本发明含蜂花粉的膳食营养补充剂可加入制备不同剂型所需的各种常规辅料,如润滑剂、抑菌剂等。
所述含蜂花粉的膳食营养补充剂为颗粒剂、胶囊剂(包括胃溶、肠溶、缓释胶囊)、片剂(包括***片、咀嚼片、分散片、缓控释片、咀嚼片、肠溶片、泡腾片、口腔崩解片、异型片)、丸剂、膏剂或口服溶液剂(口服液、饮品)。
有益效果:本发明提供的含蜂花粉的膳食营养补充剂及其制备方法,是根据中医整体观、阴阳五行理论及现代药理研究科学配伍而成,不仅增强了蜂花粉及其他原料单用以补充机体营养的效果,还能够均衡营养,并通过五脏的协调作用全面提高机体免疫力,预防疾病和亚健康。本发明所涉及的原料均是新资源食品或药食两用食品,健康、安全,对人体无毒副作用,产品则是符合人体口感及功能作用的绿色安全、健康的具有保健作用的食品,辅以方便的剂型更适合现代人的都市生活节奏。值得一提的是,本产品加工过程中所用到的三大技术真空冷冻干燥技术、气流超微粉碎技术和微粉包合技术是有机地统一在一起、不可分割的,是通过生产实践证实的,而不是简单技术的叠加,更不是本领域技术人员能够设想到的,一方面这三个技术能够保证蜂花粉及其他原料的营养成分不被破坏(尤其是热敏性较强的维生素类物质),还能充分地在人体中消化吸收,而且三大技术中涉及到的一些关键参数也保证了上述效果的实现。因此,结合三大技术并通过蜂花粉科学配伍人参、黄精等原料,保证了本发明膳食营养补充剂能够充分保留原料的营养和活性成分,均衡补充营养,全面提升免疫力,预防疾病和亚健康。
具体实施方式
下面实施例对本发明作更进一步的说明。
一种含蜂花粉的膳食营养补充剂,包括以下质量份数的原料:蜂花粉1-15份,人参(人工种植)1-5份,黄精1-10份、复合氨基酸粉1-10份、牛磺酸1-10份;
还可以包括鹿胶1-5份、鹿血1-5份、龙眼肉1-8份、佛手1-6份、香薷1-9份、桔红1-5份、胖大海1-5份、香橼1-8份、莱菔子1-6份、黄芥子1-8份、紫苏子1-6份、橘皮1-6份、昆布1-6份、山楂1-8份、决明子1-7份、阿萨伊果1-8份、诺丽果浆1-6份、杜仲雄花1-6份、薏苡仁1-6份、酵母-β提取物0.1-0.5、γ-氨基丁酸0.01-0.1份、益生菌粉0.01-0.5份,甘草1-5份、白芷1-5份、白果1-5份、白扁豆1-5份、百合1-5份、肉豆蔻1-5份、肉桂1-5份、余甘子1-5份、杏仁(甜、苦)1-5份、沙棘1-5份、牡蛎1-5份、芡实1-5份、赤小豆1-5份、阿胶1-5份、鸡内金1-5份、麦芽1-5份、昆布1-5份、枣(大枣、酸枣、黑枣)1-5份、罗汉果1-5份、郁李仁1-5份、金银花1-5份、青果1-5份、鱼腥草1-5份、姜(生姜、干姜)1-5份、枳椇子1-5份、枸杞子1-5份、栀子1-5份、砂仁1-5份、胖大海1-5份、茯苓1-5份、香薷1-5份、桃仁1-5份、桑叶1-5份、桑椹1-5份、桔红1-5份、桔梗1-5份、益智仁1-5份、荷叶1-5份、莱菔子1-5份、莲子1-5份、高良姜1-5份、淡竹叶1-5份、淡豆豉1-5份、菊花1-5份、菊苣1-5份、黄芥子1-5份、黄精1-5份、紫苏1-5份、紫苏籽1-5份、葛根1-5份、黑芝麻1-5份、黑胡椒1-5份、槐米1-5份、槐花1-5份、蒲公英1-5份、蜂蜜1-5份、榧子1-5份、酸枣仁1-5份、鲜白茅根1-5份、鲜芦根1-5份、橘皮1-5份、薄荷1-5份、薤白1-5份、覆盆子1-5份、藿香1-5份、玫瑰茄1-5份等,或根据具体需要适当选择1-5种进行配比。
本发明一种含蜂花粉的膳食营养补充剂,主要工艺:
原料预处理→真空冷冻干燥→气流超微粉碎→微粉包合→制剂→灌装→封口包装;
1、原料的处理:(1)、蜂花粉,选择符合<GB/T 30359 蜂花粉>质量要求的花粉,真空冷冻干燥,使其含水量≤5%,再经气流粉碎机超微粉碎,使其目数>400目,备用。
(2)、鹿胶、鹿血、人参(人工种植)、黄精、龙眼肉、佛手、香薷、桔红、胖大海、香橼、莱菔子、黄芥子、紫苏子、橘皮、昆布、山楂、决明子、阿萨伊果、诺丽果浆、杜仲雄花、薏苡仁、甘草、白芷、白果、白扁豆、百合、肉豆蔻、肉桂、余甘子、杏仁(甜、苦)、沙棘、牡蛎、芡实、赤小豆、阿胶、鸡内金、麦芽、枣(大枣、酸枣、黑枣)、罗汉果、郁李仁、金银花、青果、鱼腥草、姜(生姜、干姜)、枳椇子、枸杞子、栀子、砂仁、茯苓、香薷、桃仁、桑叶、桑椹、桔红、桔梗、益智仁、荷叶、莲子、高良姜、淡竹叶、淡豆豉、菊花、菊苣、黄芥子、黄精、紫苏、葛根、黑芝麻、槐米、槐花、蒲公英、蜂蜜、榧子、酸枣仁、鲜白茅根、鲜芦根、薄荷、薤白、覆盆子、藿香、玫瑰茄分别进行预处理,真空冷冻干燥,使其含水量≤5%,再经气流粉碎机超微粉碎,使其颗粒目数>400目,或直接经水(醇)提取得到提取物,备用。
(3)酵母-β提取物、γ-氨基丁酸、复合氨基酸粉、牛磺酸要符合相应的国家标准,益生菌要选择活性在1×1010cfu/g以上的,备用。
2、上述生产工艺和原料处理过程中涉及到的真空冷冻干燥,其制冷温度要≤-50℃~-60℃,真空度最大至80pa~100pa,冻干后水分≤5%。①常温或高温下干燥,会造成花粉营养成分的损耗和流失,降低花粉的利用率和生物利用度。②在低温冻干过程中,细胞内的水分形成冰晶,导致细胞膜破裂,真空冷冻干燥的温度愈低,这种破裂的程度愈大,破壁效果更明显,但这对设备要求更高,生产投入更多。所以制冷温度控制在≤-50℃~-60℃,且真空度最大至80pa~100pa,不仅能达到细胞膜破裂的效果,还能节约成本,便于投入生产。③真空冷冻干燥过程中,蜂花粉的水分由液态迅速变为固态,体积变大、膨胀,再加上冰晶使细胞膜破裂,水分升华的过程中,就促使细胞壁破裂,达到破壁的效果。因此,控制好真空冷冻干燥过程,不仅能够降低水分含量,还能有一定的破壁效果。
3、上述生产工艺和原料处理过程中涉及到的气流超微粉碎,颗粒目数>400目。①之所以优选气流式超微粉碎,是因为气流式超微粉碎不会在粉碎过程中导致局部温度过高而破坏蜂花粉的活性,也不会引入重金属而使重金属超标。②气流超微粉碎是在气流作用下,使物料高速相互碰撞而达到破壁的效果,而且粒径分布均匀,便于制剂和进一步生产加工。当颗粒目数>400时,基本可以保证其100%破壁,既节约成分,又便于生产。
3、上述生产工艺中涉及到的微粉包合,并不是通过加入麦芽糊精的包埋技术,也不是用高分子材料做成的发挥缓释作用的微囊包被技术。①微粉包合技术中所述的“微粉”为超微粉碎后的粉体,该粉体不仅会产生静电吸附成团状,而且水冲服时极易成团,通过不引入外来物质改变原有粉体成分构成的前提下,通过“唤醒”粉体自身物质的粘性,将微粉包合成80~100目的颗粒,即本发明中的微粉包合技术。②微粉包合的另外一大优势在于能够增大粉体在体内的利用率。超微粉体粒径太小且吸附性强,在胃中很容易被包裹在其它食物中而代谢掉,没有充分被人体吸收,利用率低,而微粉包合后的颗粒,不会被其他食物包裹,能够参与人体新陈代谢,利用度高。
4、本发明一种含蜂花粉的膳食营养补充剂,辅以相应的辅料并结合相关制剂工艺,制备的产品剂型为颗粒剂,胶囊剂(包括胃溶、肠溶、缓释胶囊),片剂(包括***片、咀嚼片、分散片、缓控释片、咀嚼片、肠溶片、泡腾片、口腔崩解片、异型片),丸剂,膏剂或口服溶液剂(口服液、饮品)。
5、有益效果:本发明提供的一种含蜂花粉的膳食营养补充剂及其制备方法,是根据中医整体观、阴阳五行理论及现代药理研究科学配伍而成,不仅增强了单用蜂花粉补充机体营养的效果,还能够通过五脏的协调作用全面提高机体免疫力,预防疾病和亚健康。本发明所涉及的原料均是新资源食品或药食两用食品,健康、安全,对人体无毒副作用,产品则是符合人体口感及功能作用的绿色安全、健康的保健食品,辅以方便的剂型更适合现代人的都市生活节奏。值得一提的是,本产品加工过程中所用到的三大技术真空冷冻干燥技术、气流超微粉碎技术和微粉包合技术是有机地统一在一起、不可分割的,而不是简单技术的叠加,更不是本领域技术人员能够设想到的,一方面这三个技术能够保证蜂花粉及其他原料的营养成分不被破坏(尤其是热敏性较强的维生素类物质),还能充分地在人体中消化吸收,而且三大技术中涉及到的一些关键参数也保证了上述效果的实现。因此,结合三大技术并通过蜂花粉配伍人参、黄精等原料,保证了本发明膳食营养补充剂能够充分保留原料的营养和活性成分,全面提升免疫力,预防疾病和亚健康。
适应人群:产品主要适用人群为营养不良人群、术后人群、免疫力低下人群等。
使用方法:口服,根据产品剂型,选择不同的服用量和服用次数。
实施例1 蜂花参精片的制备
配方:蜂花粉12份,人参2份,黄精2份、复合氨基酸粉4份、牛磺酸3份、鹿胶1份、鹿血1份、龙眼肉1份、佛手1份、香薷1份、桔红1份、胖大海1份、香橼1份、莱菔子1份、黄芥子1份、紫苏子1份、橘皮1份、昆布1份、山楂1份、决明子1份、阿萨伊果1份、诺丽果浆1份、杜仲雄花1份、薏苡仁1份、酵母-β提取物0.1份、γ-氨基丁酸0.01份、益生菌粉0.01份,甘草1份、白芷1份、白果1份、白扁豆1份、百合1份、肉豆蔻1份、肉桂1份、余甘子1份、杏仁1份、沙棘1份、牡蛎1份、芡实1份、赤小豆1份、阿胶1份、鸡内金1份、麦芽1份、昆布1份、枣1份、罗汉果1份、郁李仁1份、金银花1份、青果1份、鱼腥草1份、姜1份、枳椇子1份、枸杞子1份、栀子1份、砂仁1份、胖大海1份、茯苓1份、香薷1份、桃仁1份、桑叶1份、桑椹1份、桔红1份、桔梗1份、益智仁1份、荷叶1份、莱菔子1份、莲子1份、高良姜1份、淡竹叶1份、淡豆豉1份、菊花1份、菊苣1份、黄芥子1份、黄精1份、紫苏1份、紫苏籽1份、葛根1份、黑芝麻1份、黑胡椒1份、槐米1份、槐花1份、蒲公英1份、蜂蜜1份、榧子1份、酸枣仁1份、鲜白茅根1份、鲜芦根1份、蝮蛇1份、橘皮1份、薄荷1份、薏苡仁1份、薤白1份、覆盆子1份、藿香1份、玫瑰茄1份。
辅料:硬脂酸镁0.01份、麦芽糊精1份、山梨糖醇2份
蜂花粉:被誉为“浓缩的天然药库”、“全能的营养库”、“内服的化妆品”、“浓缩的氨基酸”,含有丰富的蛋白质、氨基酸、多糖、维生素、微量元素等活性成分和营养成分,是“人类天然食品中的瑰宝”。特别是本产品中的蜂花粉选用的是茶花粉,其氨基酸含量为花粉之最,微量元素锰、钴、铬及烟酸含量均比普通花粉高,为保健、医疗、美容及防癌的首选花粉;而且茶花粉对高血压、血脂异常、慢性便秘及神经衰弱有明显疗效。另外,茶花粉还是美容养颜之佳品,可使皮肤白嫩、细腻。
人参:人参得土中清阳之气,禀春升少阳之令而生,“滋阴补生,扶正固本”之极品。性秉中和,善补脾肺之气。脾为生化之源,肺主一身之气,故而脾肺之气充足则一身之气皆旺盛,所以人参为大补元气之品。且又可益气生津,人体之气血津液充沛则精神安然,故为治疗虚劳内伤之要药本品补气之力甚强。久服轻身延年者,纯阳则充举,气积则身轻,五脏皆实,延年可知矣。
复合氨基酸:氨基酸,是构成生物体蛋白质并同生命活动有关的最基本的物质,是在生物体内构成蛋白质分子的基本单位,与生物的生命活动有着密切的关系。它在人体内具有特殊的生理功能,是生物体内不可缺少的营养成分之一,与人体新陈代谢、生老病死紧密相关。
酵母β-葡聚糖:是一种良好的生物效应调节剂,量的动物试验和临床试验已经证明酵母葡聚糖具有增强免疫力、抗肿瘤、消炎、抗辐射、降低血脂和促进伤口愈合等生理功能。酵母葡聚糖口服后经肠道淋巴***进入血液循环,人体巨噬细胞(一种非特异性免疫细胞,能快清除人体外来抗原)表面有特异性的酵母葡聚糖受体,识别酵母葡聚糖后能够快速激活巨噬细胞活性,达到快速增强免疫力、抗肿瘤、抗辐射、消炎等功能。免疫力低下的中老年人、血脂异常患者、经常感冒患者、肿瘤病人、肿瘤放化疗病人适宜服用酵母葡聚糖。
鹿胶:由梅花鹿或马鹿鹿皮熬制而得。味咸,性温,归肝,肾经,主治补气,涩虚精,强筋健骨.可用于身体瘦弱,腰酸耳鸣,头晕 目眩,虚弱久 咳,痰中带血,虚喘气短,妇女经血不调,崩漏带下,性偏于温,既能补阳,又可滋阴补血、止血。
鹿血:含有的蛋白质中富含19种氨基酸及多种酶类,还含多种脂类、游离脂肪酸类、固醇类、磷脂类、激素类、维生素类和多糖类等。灰分占3%~4%,并含多种常量和有益微量元素。特别是鹿血中还含有Y-球蛋白,胱氨酸、赖氨酸,与心脏机能相关的磷酸肌酸激酶、辅酶等。
龙眼肉:补益心脾,养血安神。用于气血不足、心悸怔忡、健忘失眠、血虚萎黄。据现代研究,龙眼鲜食,味甜美爽口,且营养价值甚高,富含高碳水化合物、蛋白质、多种氨基酸和维生素B、C、钙、磷、铁、酒石酸、腺膘呤等,其中尤以含维生素P量多,对中老年人而言,有保护血管、防止血管硬化和脆性的作用。
佛手:入肝、脾、胃三经,有理气化痰、止呕消胀、舒肝健脾、和胃更多种药用功能。对老年人的气管炎、哮喘病有明显的缓解作用;对一般人的消化不良、胸腹胀闷,有更为显著的疗效。佛手可制成多种中药材,久服有保健益寿的作用。每100克佛手瓜的果实中含有水分90-92克,蛋自质0.9-1.2克,碳水化合物2.6-7.7克,维生素C12-22毫克,胡萝卜素20微克。钾的含量较高,可达190毫克,核黄素0.1毫克,钙500毫克、磷320毫克、铁40毫克、钠10毫克、铜0.03毫克、镁7毫克、锌8.35微克、硒2.3微克。此外还含有叶酸、泛酸、烟酸等。
香薷:发汗解暑,行水散湿,温胃调中。治夏月感寒饮冷,头痛发热,恶寒无汗,胸痞腹痛,呕吐腹泻,水肿,脚气。
桔红:味辛、苦,辛能横行散结,苦能直行下降,为利气要药。盖治痰须理气,气利痰自愈,故用入肺脾,主一切痰病,功居诸痰药之上。佐竹茹以疗热呃,助青皮以导滞气,同苍术、厚朴平胃中之实,合葱白、麻黄表寒湿之邪,消谷气,解酒毒,止呕吐,开胸膈痞塞,能推陈致新,皆辛散苦降之力也。用于风寒咳嗽,喉痒痰多,食积伤酒,呕恶痞闷。临床实际证明,对肺痨、支气管炎、长期胃痛、止咳化痰等有独特疗效。
胖大海:味甘,凉,性寒。能清肺化痰,利咽开音,润肠通便。质轻宣散,上入肺经清宣肺气,为喉科良药;下归大肠经清肠通便,用治热结便秘所致的上部火毒证,因药力较弱,只适用于轻症。饮食方面,肺热咳嗽、牙龈肿痛、目赤、咽喉疼痛以及急性扁桃体炎、慢性便秘、痔疮、干咳无痰、声音嘶哑、大便出血、骨蒸内热、三焦火症、吐血下血等病症患者适宜食用;此外,还可以在炎炎夏季当做清热解暑饮料食用。
香橼:理气,舒郁,消痰,利膈。治胃痛胀满,痰饮咳嗽气塑,呕哕少食。从药用上而言,香橼下气,去痰水,心下气痛,用于消化不良、胸闷痰多、呕吐等症;对于慢性胃炎,神经性胃痛很合适。
莱菔子:辛、甘,平。归肺、脾、胃经。消食除胀,降气化痰。用于饮食停滞,脘腹胀痛,大便秘结,积滞泻痢,痰壅喘咳。莱菔子含有少量挥发油及45%的脂肪油,挥发油中含有甲硫,α-β-己烯醛和β-、γ-己烯醇等;脂肪油中含多量芥酸、亚油酸、亚麻酸、芥子酸甘油酯等,另还含芥子碱、莱菔子素、正十烷、正十八碳酸(硬脂酸)、β,γ-谷甾醇、辛烯醛、邻苯二甲酸丁二脂、芥子碱硫酸氢盐以及氨基酸、蛋白质、酶、多糖、酚类、生物碱、黄酮、植物甾醇、维生素及辅酶Q等。
黄芥子:性温、味辛,有润肺化痰、消肿止痛、温中散寒、利水化瘀、通经络、消肿毒之功效,主治胃寒呕吐、心腹疼痛、肺寒咳嗽、痹症、喉痹、流痰、跌打损伤等症。
紫苏子:降气消痰,平喘,润肠。用于痰壅气逆,咳嗽气喘,肠燥便秘。解表散寒,行气和胃。用于风寒感冒,咳嗽气喘,妊娠呕吐,胎动不安。又可解鱼蟹中毒。紫苏子含脂肪油(45.30%)及维生素B1、蛋白质17%,油中富含不饱和脂肪酸和亚麻酸(linolenic acid)56.8%,亚油酸(linoleic acid)17.6%。
橘皮:味辛而微苦,温,入脾、肺经。有理气调中,燥湿化痰功效,可用于治疗脾胃气滞,脘腹胀满,呕吐,或湿浊中阻所致胸闷、纳呆、便溏等。含挥发油1.9%~3.5%.其中主要为柠檬烯(Limonene);尚有α-侧柏烯(α-Thujene)、α-蒎烯(α-Pinene)、β-蒎烯(β- Pinene)、β-月桂烯(β-Myrcene)、桧烯(Sabine- ne)、辛醛(Octanal)、α-水芹烯(α-Phellandrene)、α-松油烯(α-Terpinene)、对-聚伞花烯(p-Cymene)、芳樟醇(Linalool)、麝香草酚(Thymol)、香茅醛(Citronellal)等多种成分。此外,还含橙皮甙(Hesperidin)、新橙皮甙(Neohesperidin)、柑橘素(Tangeretin)、黄酮化合物、枸橼醛、β-谷甾醇(β-Sitosterol)、对羟福林(Synephrine)等。
昆布:气腥,味咸。归肝、胃、肾经。有软坚散结,消痰,利水之功能。用于痰饮水肿。软坚散结,消痰,利水。瘿瘤、瘰疬、睾丸肿痛、痰饮水肿。昆布是一种营养价值很高的蔬菜,每百克干昆布中含:粗蛋白8.2克,脂肪0.1克,糖57克,粗纤维9.8克,无机盐12.9克,钙2.25克,铁0.15克,以及胡萝卜素0.57毫克,硫胺素(维生素B1)0.69毫克,核黄素(维生素B2)0.36毫克,尼克酸16毫克,能发出262干卡热量。与菠菜、油菜相比,除维生素C外,其粗蛋白、糖、钙、铁的含量均高出几十倍。
山楂:酸甘,微温。入脾、胃、肝经。消食积,散瘀血,驱绦虫。治肉积,症瘕,痰饮,痞满,吞酸,泻痢,肠风,腰痛,疝气产后儿枕痛,恶露不尽,小儿乳食停滞。消食健胃,行气散瘀。用于肉食积滞、胃烷胀满、泻痢腹痛、瘀血经闭、产后瘀阻、心腹刺痛、疝气疼痛、高血脂症。山楂的主要成分为黄酮类及有机酸类化合物。黄酮类化合物主要有牡荆素(vitexin)、槲皮素(quercetin)、槲皮苷(quercitin)、金丝桃苷(hyperoside)、3 7,4’,5,7一四羟基黄酮一7一葡萄糖苷(3 7,4 7,5,7一tetrahydroxy flavone一7一glucoside)和芦丁(rutoside);有机酸主要有山楂酸(maslinic acid)、柠檬酸(citric acid)、熊果酸(ur—solic acid)等。另外还含有磷脂(phosphatide)、维生素C(vitamin C)、维生素B2(vita—min B2)等。
决明子:味苦、甘、咸,性微寒,入肝、肾、大肠经;润肠通便,降脂明目,治疗便秘及高血脂,高血压。用于目赤涩痛,羞明多泪,头痛眩晕,目暗不明,大便秘结。决明子除含有糖类、蛋白质、脂肪外,还含有人体必需的微量元素铁、锌、锰、铜、镍、钴、钼等。所含大黄素、大黄酸对人体有平喘、利胆、保肝、降压功效,并有一定抗菌、消炎作用。其中大黄素葡萄糖甙、大黄素蒽酮、大黄素甲醚,具有降低血清胆固醇和强心作用。决明子素具有a-羟基,可与金属素合成络合物,对金属元素吸收有很大影响。现代临床用决明子治疗高脂血症收效满意,决明子水煎或制成片剂服用。民间常用决明子炒黄末,代茶饮,有预防和治疗疾病的保健功能。
阿萨伊果:拥有地球上任何其它水果都不可能达到的营养和对治疗疾病的特性,是莓中的极品。阿萨伊果抗氧化作用是水果含抗氧化剂最大的野生黑覆盒子的1.8倍、野生蓝莓的2.4倍、及红葡萄酒的33倍;科学研究和医学界已经证明抗氧化剂是预防疾病、修补细胞、养颜排毒、延缓衰老的最重要的营养素。阿扎伊尔果可帮助伤口愈合、清血、改善贫血、腹泻、发烧、出血、黄疸、肝脏疾病、寄生虫和溃疡。而秘鲁当地传统医学则用为糖尿病、发烧、掉头发、出血、肝炎、黄疸、肾脏问题、肝脏疾病、疟疾、***、经期疼痛和肌肉酸痛都有显著功效。
诺丽果浆:诺丽丰富的营养成分使它成为“超级水果”,载誉全世界。成熟后诺丽果的表皮从金黄变为乳白,熟透的诺丽果***,并发出浓烈的奶酪一样的气味,所以有人称之为“奶酪果”,其独特的气味,是富含有效成分的标志。诺丽富含人体最需要的多种酶(酵素)、氨基酸、维他命、蛋白质、矿物质和生物碱等营养成分,有关研究不断地证实这些物质对身体的神奇作用。诺丽果包含有赛洛宁原、活性酵素、β-胡萝卜素、烟碱素、蛋白质、碳酸盐、叶酸、生物素、泛酸、血清素、膳食纤维、酵素、维生素A、维生素B群、维生素C、维生素D、维生素E、维生素K、钙、铁、镁、锌、碘、磷、铜、铬、锰、硫、钠、钾、硒、锗、钼等150多种营养元素。
杜仲雄花:含60多种有效植物成分,如木质素类,环烯醚萜类、苯丙素类活性物质(如京尼平甙酸、绿原酸、桃叶珊瑚甙)、松脂醇双糖甙、黄酮、生物碱、氨基酸、多糖以及矿质元素Zn、Mn、Cu、Fe、Ca、P、B、Mg、K等,其中氨基酸含量达21.47%,钙的含量达0.92%,锌含量达51mg/100g,分别是杜仲叶的1.8倍和5.2倍,有效成分最为全面,而且含量更高,杜仲雄花,汇集了所有杜仲的精华,可以说杜仲雄花具备植物杜仲所有的保健功效,而且对于“强肝、补肾、通便、安眠、降三高”的效果尤为显著!
薏苡仁:味甘、淡,性凉。归脾、胃、肺经。有利水渗透湿,健脾止泻,除痹,排脓,解毒散结的作用。用于水肿,脚气,小便不利,脾虚泄泻,湿痹拘挛,肺痈,肠痈;赘疣,癌肿。薏苡仁的营养价值很高,含有蛋白质、脂肪、碳水化合物、粗纤维、矿物质钙、磷、铁、维生素B1、维生素B2、烟酸、淀粉、亮氨酸、精氨酸、赖氨酸、酪氨酸、脂肪酸、苡仁酯、苡仁油、谷甾醇、生物碱等营养成分。其中蛋白质、脂肪、维生素B1的含量远远高于大米。
甘草:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
白芷:散风除湿,通窍止痛,消肿排脓。用于感冒头痛,眉棱骨痛,鼻塞,鼻渊,牙痛,白带,疮疡肿痛。,白芷除了具有解热、镇痛、抗炎等作用,还能改善局部血液循环,消除色素在组织中过度堆积,促进皮肤细胞新陈代谢,进而达到美容的作用,临床常用治风寒感冒、头痛、牙痛、眉棱骨痛、鼻渊、肠风痔漏、赤白带下、痈疽疮疡、毒蛇咬伤等。
白果:白果,又称银杏,银杏的种仁,除淀粉、蛋白质、 脂肪、糖类之外,还含有维生素C、核黄素、胡萝卜素、钙、磷、铁、钾、镁等微量元素以及银杏酸、白果酚、五碳多糖,脂固醇等成分,营养丰富,而且对于益肺气、治咳喘、止带虫、缩小便、平皴皱、护血管、增加血流量等具有良好的医用效果和食疗作用。经常食用白果,可以滋阴养颜抗衰老,扩张微血管,促进血液循环,使人肌肤、面部红润,精神焕发,延年益寿,是老幼皆宜的保健食品和款待国宾上客的特制佳肴。种仁中的黄酮甙、苦内脂对脑血栓、老年性痴呆、高血压、高血脂、冠心病、动脉硬化、脑功能减退等疾病还具有特殊的预防和治疗效果。
白扁豆:白扁豆味甘,性微温,有健脾化湿,利尿消肿,清肝明目等功效。白扁豆治暑湿吐泻、暑多夹湿,夏日暑湿伤中,脾胃不和,易致吐泻。白扁豆能健脾化湿以和中。白扁豆治脾气虚证,白扁豆能补气以健脾,以白扁豆作为人参、白术等药物的辅助。白扁豆还可用于脾虚湿浊下注之白带过多,宜与白术、苍术、芡实等补气健脾除湿之品配伍。白扁豆,营养价值较高,矿物质和维生素含量比大部分根茎菜和瓜菜都高,味亦鲜嫩可口。据中国科学院卫生研究所编的《食物成分表》:每百克白扁豆含蛋白质2.8克,脂肪0.2克,糖5.4克,热量35千卡,粗纤维1.4克,钙116毫克,铁1.5毫克,胡萝卜素0.32毫克,硫胺酸0.05毫克,核黄酸0.07毫克,尼克酸0.7毫克,抗坏血酸13毫克。白扁豆作为滋补佳品,夏暑又是一种清凉饮料。
百合:合除含有蛋白质21.29%、脂肪12.43%、还原糖11.47%、淀粉1.61%,及钙、磷、铁、每百克含1.443毫克维生素B、21.2毫克维生素C等营养素外,还含有一些特殊的营养成分,如秋水仙碱等多种生物碱。这些成分综合作用于人体,不仅具有良好的营养滋补之功,而且还对秋季气候干燥而引起的多种季节性疾病有一定的防治作用。中医上讲百合具有养心安神,润肺止咳的功效,对病后虚弱的人非常有益。
肉豆蔻:含挥发油2~9%,包括d-莰烯及α-蒎烯等。其脂肪中,肉豆蔻酸含量达70~80%,并含有毒物质肉豆蔻醚。温中,下气,消食,固肠。治心腹胀痛,虚泻冷痢,呕吐,宿食不消。
肉桂:补元阳,暖脾胃,除积冷,通血脉。治命门火衰,肢冷脉微,亡阳虚脱,腹痛泄泻,寒疝奔豚,腰膝冷痛,经闭癥瘕,阴疽,流注,及虚阳浮越,上热下寒。
余甘子:补益强气、黑发,主治风虚热气、气喘咳嗽、久服轻身、延年益寿。具有降压减肥、延缓衰老、清火润喉、解金石毒、乌发美容等35种治疗功效,是被***列为“既是食品又是药品”的健康水果。余甘果富含人体所须的18种氨基酸、16种微量元素、丰富的维生素C和SOD、有机硒,其中维生素C含量高达0.6-1.56%,比“维生素C之王”猕猴桃还要高5倍,是苹果100倍,柑桔25-50倍,且所含的维生素C相当稳定,经高温和久晒后还保存80%-98%。
杏仁(甜、苦):止咳平喘,润肠通便。杏仁富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁等营养成分。其中胡萝卜素的含量在果品中仅次于芒果,人们将杏仁称为抗癌之果。杏仁含有丰富的脂肪油,有降低胆固醇的作用,因此,杏仁对防治心血管***疾病有良好的作用;中医中药理论认为,杏仁具有生津止渴、润肺定喘的功效,常用于肺燥喘咳等患者的保健与治疗。甜杏仁作为食品,可作扁桃仁的代替品。美国研究人员的一项最新研究成果显示,胆固醇水平正常或稍高的人,可以用杏仁取代其膳食中的低营养密度食品,达到降低血液胆固醇并保持心脏健康的目的。研究者认为,杏仁中所富含的多种营养素,比如维生素E,单不饱和脂肪和膳食纤维共同作用能够有效降低心脏病的发病危险。样本中85位中老年志愿者(平均年龄56岁)的总胆固醇水平降低了7.6%,低密度脂蛋白胆固醇水平下降了9%,也未造成体重的增加。
沙棘:止咳祛痰,消食化滞,活血散瘀。用于咳嗽痰多、消化不良、食积腹痛、跌扑瘀肿、瘀血经闭。沙棘果实营养丰富,据测定其果实中含有多种维生素、脂肪酸、微量元素、亚油素、沙棘黄酮、超氧化物等活性物质和人体所需的各种氨基酸。其中维生素C含量极高,每100克果汁中,维生素C含量可达到825~1100毫克,是猕猴桃的2~3倍,素有维生素C之王的美称。含糖7.5%~10%,含酸3%~5%。沙棘可降低胆固醇,治愈心绞痛等作用,还有防治冠状动脉粥样硬化性心脏病的作用;有祛痰、止咳、平喘和治疗慢性气管炎的作用;能治疗胃和十二指肠溃疡以及消化不良等,对慢性浅表性胃炎、萎缩性胃炎、结肠炎等病症疗效显著;对烧伤、烫伤、刀烧、冻伤有很好的治疗作用;对妇女***有良好的治疗效果。
牡蛎:含80%~95%的碳酸钙、磷酸钙及硫酸钙,并含镁、铝、硅及氧化铁等.牡蛎煅烧后碳酸盐分解,产生氧化钙等。牡蛎原动物含糖原,牛磺酸,10种必需的氨基酸,谷胱甘肽,维生素A、B1.B2.D,无机质如铜、锌、锰、钡、磷及钙等,其中所含的亮氨酸、精氨酸、瓜氨酸含量最丰富,是迄今为止人类所发现的含量最为高的海洋物种之一。我国广东、福建台湾养殖较多。肉味鲜美,含有丰富蛋白质、脂肪和肝糖,可以鲜食或烹食。也可加工制成蚝豉或蚝油。壳可入药,也可烧石灰。
芡实:味甘、涩,性平。归脾、肾经。益肾固精,补脾止泻,除湿止带。用于遗精滑精,遗尿尿频,脾虚久泻,白浊,带下。芡实含有丰富的淀粉,可为人体提供热能,并含有多种维生素和微量元素物质,保证体内营养所需成分。芡实和莲子功效相仿,而其收敛镇静作用比莲子更强。
赤小豆:赤小豆含有蛋白质、脂肪、碳水化合物、粗纤维、钙、磷、铁、维生素B1、维生素B2、皂苷等营养成分。性平,味甘、酸,能利湿消肿(水肿,脚气,黄疸,泻痢,便血,痈肿)、清热退黄、解毒排脓。利尿作用,对心脏病和肾病、水肿患者均有益。富含叶酸,产妇、乳母吃红小豆有催乳的功效。具有良好的润肠通便、降血压、降血脂、调节血糖、预防结石、健美减肥的作用。
阿胶:为补血止血、滋阴润燥之良药。临床应用于血虚萎黄、眩晕心悸、肌痿无力、心烦失眠、虚风内动、肺燥咳嗽、劳咳咯血、吐血、便血崩漏等方面具有显著疗效。阿胶具有生血作用,可用于失血贫血、缺铁贫血、再生障碍贫血及年老体弱、儿童、妇女的滋补。并对儿童、青少年的生长发育具有改善作用,。长期服用阿胶,还可营养皮肤,使肌肤光洁滑润并具弹性。
鸡内金:甘,平。归脾、胃、小肠、膀胱经。健胃消食,涩精止遗,通淋化石。用于食积不消,呕吐泻痢,小儿疳积,遗尿,遗精,石淋涩痛,胆胀胁痛。鸡内金主要含有胃激素,角蛋白,氨基酸等成分。有增加胃液分泌量和胃肠消化能力,加快胃的排空速率等作用。是一种很常用的中药。
麦芽:甘,平。归脾、胃经。行气消食,健脾开胃,回乳消胀。用于食积不消,脘腹胀痛,脾虚食少,乳汁郁积,***胀痛,妇女断乳,肝郁胁痛,肝胃气痛。
枣(大枣、酸枣、黑枣):补脾和胃,益气生津,调营卫,解药毒。治胃虚食少,脾弱便溏,气血津液不足,营卫不和,心悸怔忡。妇人赃躁。含有蛋白质、脂肪、18种氨基酸(其中有8种是人体不能自动合成的在),6种有机酸,36种微量元素及丰富的维生素A、维生素C、维生素B1、维生素B2、维生素P,其中蛋白质含量比梨高出11倍,维生素C和维生素P含量最高,有维生素王之美称。大枣中所含糖类主要是葡萄糖,亦含果糖、蔗糖、由葡萄糖和果糖组成的低聚糖、***聚糖及半乳醛聚糖等.另外,还发现大枣中存在一种酸性多糖,命名为大枣果胶(Zizyphus-pectin)A。此外还含有纤维素、胡萝卜素、核黄素、树脂、黏液质、香豆素类衍生物、儿茶酚(Catechol)、鞣质(Tannin)、挥发油等。民间有“天天吃红枣,一生不显老”之说。大枣最突出的特点是维生素含量高。在国外的一项临床研究显示:连续吃大枣的病人,健康恢复比单纯吃维生素药剂快3倍以上。因此,大枣有“天然维生素丸”的美誉。
罗汉果:为***首批公布的药食两用名贵中药材,其所含罗汉果甜甙比蔗糖甜300倍,不产生热量,是饮料、糖果行业的名贵原料,是蔗糖的最佳替代品。常饮罗汉果茶,可防多种疾病,现代医学证明,罗汉果对支气管炎、高血压等疾病有显著疗效,还是起到防治冠心病、血管硬化、肥胖症的作用。营养价值高,有清热解暑、化痰止咳、凉血舒骨、清肺润肠和生津止渴等功效;可治急慢性气管炎、咽喉炎、支气管哮喘、百日咳、胃热、便秘、急性扁桃体炎等症,糖尿病患者亦宜服用。
郁李仁:含苦杏仁甙、脂肪油58.3~74.2%、挥发性有机酸、粗蛋白质、纤维素、淀粉、油酸。又含皂甙0.96%及植物甾醇、维生素B1。茎皮含鞣质6.3%、纤维素24.94%。叶含维生素C7.30毫克%。
金银花:金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。
青果:青果含蛋白质、脂肪、碳水化合物、膳食纤维、胡萝卜素、视黄醇当量、维生素B1、维生素B2、尼克酸、维生素C、钙、铁、磷、镁、锌、硒等成分。青果味甘酸,性平,具有清热解毒,利咽化痰,生津止渴,开胃降气,除烦醒酒之功效,适应于治咽喉肿痛,咳嗽吐血,菌痢,癫痫,暑热烦渴,肠炎腹泻等病症。据2010年以来研究表明,青果和青果油还有防治心脏病、胃溃疡和保护胆囊的功能。另据研究发现,孕妇及哺乳期食青果,对婴儿大脑发育有明显的促进作用,可使婴儿变聪明。近代医学研究发现,摄入钙含量丰富的物质,可减少患结肠癌和直肠癌的危险性。青果含钙量相当高,钙、磷比值远大于2,经常食用,人体中有足量的钙可与脂肪酸、胆汁酸结合形成不溶性化合物排出体外,减少对肠道的致癌作用。
鱼腥草:鱼腥草味辛,性寒凉,归肺经。能清热解毒、消肿疗疮、利尿除湿、清热止痢、健胃消食,用治实热、热毒、湿邪、疾热为患的肺痈、疮疡肿毒、痔疮便血、脾胃积热等。现代药理实验表明,本品具有抗菌、抗病毒、提高机体免疫力、利尿等作用。
姜(生姜、干姜):生姜是一种很有开发利用价值的经济作物,除含有姜油酮、姜酚等生理活性物质外,还含有蛋白质、多糖、维生素和多种微量元素,集营养、调味、保健于一身,自古被医学家视为药食同源的保健品,具有祛寒、祛湿、暖胃、加速血液循环等多种保健功能。
枳椇子:味甘,性平。入胃经。解酒毒,止渴除烦,止呕,利大小便。醉酒,烦渴,呕吐,二便不利。
枸杞子:枸杞子含有丰富的胡萝卜素、维生素A1、B1、B2、C以及钙、铁等健康眼睛的必需营养,所以俗称“明眼子”。历代医家治疗肝血不足、肾阴亏虚引起的视物昏花和夜盲症,常常使用枸杞子。著名方剂杞菊地黄丸,就以枸杞子为主要药物。民间也习用枸杞子治疗慢性眼病,枸杞蒸蛋就是简便有效的食疗方。
枸杞子色素是存在于枸杞浆果中的各类呈色物质的总称,是枸杞子的重要生理活性成分。主要包括β-胡萝卜素、少量的叶黄素及其他有色物质。枸杞子色素具有提高人体免疫功能、防止肿瘤形成及预防动脉粥样硬化等作用。枸杞有提高机体免疫力的作用,可以补气强精,滋补肝肾、抗衰老、止消渴、暖身体、抗肿瘤的功效。
栀子:清热,泻火,凉血。治热病虚烦不眠,黄疸,淋病,消渴,目赤,咽痛,吐血,衄血,血痢,尿血,热毒疮疡,扭伤肿痛。含黄酮类栀子素、果胶、鞣质、藏红花素、藏红花酸、D-甘露醇、廿九烷、β-谷甾醇。另含多种具环臭蚁醛结构的甙:栀子甙、去羟栀子甙泊素-1-葡萄糖甙,格尼泊素-1-β-D-龙胆二糖甙及小量的山栀甙。
砂仁:行气调中,和胃,醒脾。治腹痛痞胀,胃呆食滞,噎膈呕吐,寒泻冷痢,妊娠胎动。砂仁种子含挥发油,油中含乙酸龙脑酯、樟脑、樟烯、柠檬烯、β-蒎烯、苦橙油醇(nerolidol)及α-蒎烯、莰烯、桉油精、芳樟醇、α-胡椒烯、愈创木醇(guaiaol)等,另含黄酮类成分。
茯苓:味甘、淡,性平。归心、肺、脾、肾经。利水渗湿,健脾,宁心。用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。茯苓菌核含β-茯苓聚糖,约占干重93%和三萜类化合物乙酰茯苓酸、茯苓酸、3β-羟基羊毛甾三烯酸。此外,还含树胶、甲壳质、蛋白质、脂肪、甾醇、卵磷脂、葡萄糖、腺嘌呤、组氨酸、胆碱、β-茯苓聚糖分解酶、脂肪酶、蛋白酶等。
桃仁:活血祛瘀,润肠通便。用于经闭,痛经,癓瘕痞块,跌扑损伤,肠燥便秘。桃仁性甘平、味苦,入肺、肝、大肠经;有破血行瘀,润燥滑肠的功效;治经闭、痛经、瘕瘕痞块,跌打损伤、肠燥便秘。桃仁含苦杏仁苷、24-亚甲基环木菠萝烷醇、野樱苷、β-谷甾醇和菜油甾醇及它们的葡萄糖苷等,还含绿原酸、3-咖啡酰奎宁酸、苦杏仁酶、挥发油及脂肪油等。
桑叶:现代中、西医把桑叶和桑叶生物制剂作为改善糖尿病及其他各种疑难杂症的药物而使用,认为其药效极为广泛。有清肺润燥、止咳、去热、化痰、治盗汗;补肝、清肝明目、治疗头晕眼花、失眠、消除眼部疲劳;消肿、清血、治疗痢疾、腹痛、减肥、除脚气、利大、小肠;抗应激、凉血、降血压、降血脂、预防心肌梗塞、脑溢血、祛头痛、长发;降血糖等。
桑椹:中医学认为桑椹补益肝肾,滋阴养血,息风,具有主治心悸失眠、头晕目眩、耳鸣、便秘盗汗、瘰疬、关节不利等病症。成熟的桑椹果(紫、红)营养丰富,每100克含:水分81.8克,能量48千卡,蛋白质1.6~1.8克,脂肪0.3~0.4克。膳食纤维(纤维素)3.3~4.9克,碳水化合物10~12.9克,灰分1.2克,维生素A:3微克,胡萝卜素20~30微克,硫胺素0.02毫克、核黄素0.05~0.06毫克,维生素E:6.95~12.78毫克,钾33毫克,钙30毫克,磷33毫克,钾32毫克,钠1.9毫克,铁0.3毫克,锌0.25~0.27毫克,铜0.06~0.08毫克,硒4.8~6.5微克,锰0.29毫克。此外,还含有鞣酸,苹果酸,维生素C和脂肪酸等。其脂肪主要为亚油酸、油酸、软脂酸、硬脂酸和少量辛酸、壬酸、癸酸、肉豆蔻酸、亚麻酸等。
桔梗:开宣肺气,祛痰排脓。治外感咳嗽,咽喉肿痛,肺痈吐脓,胸满胁痛,痢疾腹痛。桔梗含有的已知其成分有远志酸,桔梗皂甙元及葡萄糖。又含菠菜甾醇、α-菠菜甾莳-β-D-葡萄糖甙、白桦脂醇,并含菊糖、桔梗聚糖。又从桔梗得到三个三萜烯类物质:桔梗酸A、B、及C等。
益智仁:温脾,暖肾,固气,涩精。治冷气腹痛,中寒吐泻,多唾,遗精,小便余沥,夜多小便。据现代药理研究证实,益智仁含有多种化合物、能够增强阳虚动物的脾脏和增加胸腺重量,并能改善阳虚动物的营养、体重和耐受力等,对阳虚怕冷的病人有明显的强壮和治疗作用。
荷叶:清暑利湿,升发滑阳,止血。治暑湿泄泻、眩晕,水气浮肿,雷头风,吐血,衄血,崩漏,便血,产后血晕。叶含莲碱、荷叶碱、原荷叶碱、亚美罂粟碱、前荷叶碱、N-去甲基荷叶碱、D-N-甲基乌药碱、番荔枝碱、鹅掌楸碱、槲皮素、异槲皮甙、莲甙、酒石酸、柠檬酸、苹果酸、葡萄糖酸、草酸、琥珀酸、鞣质,还含抗有丝***作用的碱性成分。
莲子:养心,益肾,补脾。涩肠。治夜寐多梦,遗精,淋浊,久痢,虚泻,妇人崩漏带下。石莲子并能止呕、开胃,常用治噤口痢。莲子中含碳水化合物(62%),蛋白质(6.6%),脂肪(2.0%),钙(0.089 %),磷(0.285%),铁(0.0064%)。脂肪中脂肪酸组成:肉豆蔻酸(myristicacid)0.04%,棕榈酸(palmiticacid)17.32%,油酸(oleic acid)21.91%,亚油酸(linoleicacid)54.17%,亚麻酸(linolenic acid)6.19%。
高良姜:温胃,祛风,散寒,行气,止痛。治脾胃中寒,脘腹冷痛,呕吐泄泻,噎脯反胃,食滞,瘴疟,冷癖。根茎含挥发油0.5~1.5%,其中主要成分是1,8-桉叶素和桂皮酸甲酯,尚有丁香油酚、蒎烯、毕澄茄烯等。根茎尚含黄酮类高良姜素、山柰素、山奈酚、槲皮素、异鼠李素等和一种辛辣成分,称高良姜酚。
淡竹叶:清热;除烦;利尿。主烦热口渴;口舌生疮;牙龈肿痛;小儿惊啼;小便赤涩;淋浊。用于热病烦渴,小便赤涩淋痛,口舌生疮。竹叶中含有大量的黄酮类化合物和生物活性多糖及其它有效成分,如酚酸类化合物、蒽醌类化合物、萜类内酯、特种氨基酸和活性肤、锰、锌、硒等微量元素。竹叶中所含的功能因子主要是黄酮糖苷和香豆素类内酯。竹叶提取物具有优良的抗自由基、抗氧化、抗衰老、降血脂和血胆固醇的作用。
淡豆豉:味苦、气香宣散,具有疏散解表,宣郁除烦的功效;主治外感表症,恶寒发热,胸中烦闷,虚烦不眠,口舌生疮。凡外感表症,无论风寒,风热均可应用,惟效力较弱,故常与其他解表药配伍使用。若湿热郁蒸之酒疸,心中热痛者,可与大黄、栀子同用,以清热利湿。
菊花:具有疏风、清热、明目、解毒之功效。主要治疗头痛、眩晕、目赤、心胸烦热、疔疮、肿毒等症。菊花具有治疗冠心病、降低血压、预防高血脂、抗菌、抗病毒、抗炎、抗衰老等多种药理活性。菊花中含有挥发油、菊甙、腺嘌呤、氨基酸、胆碱、水苏碱、小蘖碱、黄酮类、菊色素、维生素,微量元素等物质,可抗病原体,增强毛细血管抵抗力;其中的类黄酮物质已经被证明对自由基有很强的清除作用,而且在抗氧化,防衰老等方面卓有成效。从营养学角度分析,植物的精华在于花果。菊花花瓣中含有17种氨基酸,其中谷氨酸、天冬氨酸、脯氨酸等含量较高。此外,还富含维生素及铁、锌、铜、硒等微量元素,因而具有一般蔬果无法比拟的作用。
菊苣:含有多种对人体有益的营养成分,包括蛋白质、脂肪、膳食纤维和氨基酸等,另外钙、维生素和胡萝卜素的含量也很高,可以满足身体器官对多种营养的需要。菊苣是一种可以入药的特色植物,它味微苦,咸,性质寒凉,清热解毒和利尿消肿是它的重要功效,可以用于人黄疸和湿热以及肾炎水肿等不良疾病的治疗
葛根:升阳解肌,透疹止泻,除烦止温。治伤寒、温热头痛项强,烦热消渴,泄泻,痢疾,癍疹不透,高血压,心绞痛,耳聋。葛根的主要成分是淀粉,此外含有约12%的黄酮类化合物,包括大豆(黄豆)甙、大豆甙元、葛根素等10余种,并含有胡萝卜甙、氨基酸、香豆素类等。葛根中提出的黄酮能增加大脑及冠状血管血流量,降低血管阻力。所含的大豆黄酮具有解痉作用,还能降低血糖,并有解热及***样作用。
黑芝麻:为胡麻科芝麻的黑色种子,含有大量的脂肪和蛋白质,还含有糖类、维生素A、维生素E、卵磷脂、钙、铁、铬等营养成分。有健胃、保肝、促进红细胞生长的作用,同时可以增加体内黑色素,有利于头发生长。味甘,性平。有滋补肝肾,益血润肠,通便,通乳的功能。
槐花:凉血止血,清肝泻火。用于便血、痔血、血痢、崩漏、吐血、衄血、肝热目赤、头痛眩晕。每100克鲜品含水分78克,蛋白质 3.1克,脂肪0.7克,碳水化合物15克,钙8.3毫克,磷69毫克,铁3.6毫克,胡萝卜素0.04毫克,维生素 B1 0.04毫克,维生素B2 0.18毫克,尼克酸6.6毫克,维生素C 66毫克。此外,还含有芸香甙、槐花素等物质。
槐米:凉血止血,清肝降火。主治肠风便血,痔血,尿血,血淋,崩漏,咳血,赤白痢,目赤,疮毒,高血压等病症。
蒲公英:清热解毒,利尿散结。治急性乳腺炎,淋巴腺炎,瘰疬,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎,胃炎,肝炎,胆囊炎,***。蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分,有利尿、缓泻、退黄疸、利胆等功效。蒲公英同时含有蛋白质、脂肪、碳水化合物、微量元素及维生素等,有丰富的营养价值,可生吃、炒食、做汤,是药食兼用的植物。
蜂蜜:蜂蜜是一种营养丰富的天然滋养食品,也是最常用的滋补品之一。据分析,含有与人体血清浓度相近的多种无机盐和维生素、铁、钙、铜、锰、钾、磷等多种有机酸和有益人体健康的微量元素,以及果糖、葡萄糖、淀粉酶、氧化酶、还原酶等,具有滋养、润燥、解毒、美白养颜、润肠通便之功效,对少年儿童咳嗽治疗效果很好。
榧子:味甘、性平,入肺、胃、大肠经;能消除疳积、润肺滑肠,化痰止咳,适用于多种便秘,疝气、痔疮、消化不良、食积、咳痰症状。含较多维生素A,对眼睛干涩、易流泪,夜盲等症状有预防和缓解的功效;主治钩虫病、绦虫病、小儿疳积、蛔虫病、燥咳、便秘、痔疮。脂肪酸和维生素E含量较高,常食可润泽肌肤、延缓衰老;榧仁内含4种脂碱,对淋巴细胞性白血病有明显的抑制作用,对治疗和预防淋巴肉瘤有益,可用于治疗多种肠道寄生虫病,杀虫能力较强。
酸枣仁:有宁心安神;养肝;敛汗的功效,主治虚烦不眠;惊悸怔忡;体虚自汗、盗汗。酸枣仁含有生物碱,皂苷和黄酮等多种药理成分。具有镇静、催眠、镇痛、抗惊厥、降血脂、抗血小板聚集、增强免疫功能、降压、抗缺氧、抗心肌缺血、抗心率失常、抗衰老、抗辐射等作用。酸枣仁还含有非常丰富的维生素C,平时食用可以补充身体所需的维生素C,维持身体营养平衡宁心、安神。
鲜白茅根:凉血,止血,清热,利尿。治热病烦渴,吐血,衄血,肺热喘急,胃热哕逆,淋病,小便不利,水肿,黄疸。白茅根中含有丰富的钾盐,故利尿作用十分明显,它除了含芦竹素、白茅素、羊齿烯醇及西米杜鹃醇外,还含有枸橼酸、苹果酸、草酸、蔗糖、果糖、葡萄糖等成分。
鲜芦根:清热生津、除烦、止呕、利尿,主治热病烦渴、胃热呕吐、肺热咳嗽、肺痈吐脓、热淋涩痛。根茎含多量的维生素B1、B2、C以及蛋白质5%,脂肪1%,碳水化合物51%,天冬酰胺0.1%。又含氨基酸,脂肪酸,甾醇,生育酚,多元酚如咖啡酸和龙胆酸。还含2,5-二甲氧基-对-苯醌,对-羟基苯甲醛,丁香醛,松柏醛,香草酸,阿魏酸,对-香豆酸及二氧杂环已烷木质素。后者的氧化降解产物为苯丙烷的愈创木酚基,丁香酚基和4-羟基苯基的衍生物。另含薏苡素,小麦黄素,β-香树脂醇,蒲公英赛醇,蒲公英寒酮和由***糖,木糖和葡萄糖按摩尔比10:19:94所组成的相对分子质量约为20000的多糖。又含游离的脯氨酸和三甲铵乙内酯类化合物。
薄荷:薄荷具有医用和食用双重功能,主要食用部位为茎和叶,也可榨汁服。在食用上,薄荷既可作为调味剂,又可作香料,还可配酒、冲茶等。每100克干薄荷中,含水分9.6克、蛋白质6.8克和纤维31.1克,能提供870.7千焦的热量。薄荷是中国常用中药,幼嫩茎尖可作菜食,全草又可入药,治感冒发热喉痛,头痛,目赤痛,肌肉疼痛,皮肤风疹搔痒,麻疹不透等症,此外对痈、疽、疥、癣、漆疮亦有效。
薤白:通阳散结,行气导滞。用于胸痹心痛,脘腹痞满胀痛,泻痢后重。每100克可食部分含水分29克,蛋白质4.4克,脂肪0.2克,碳水化合物23.6克,粗纤维0.7究,钙5毫克,磷44毫克,铁0.4毫克,维生素 B1 0.24毫克,B2 0.03毫克,维生素C 3毫克,尼克酸 0.9毫克。
覆盆子:覆盆子果实含有相当丰富的维生素A、维生素C、钙、钾、镁等营养元素以及大量纤维。每100克覆盆子,水分占87%,含蛋白质0.9克、纤维4.7克,能提供209.3千焦的热量。覆盆子能有效缓解心绞痛等心血管疾病,但有时会造成轻微的腹泻。覆盆子果实酸甜可口,有“黄金水果”的美誉。树莓含有丰富的水杨酸、酚酸等物质。水杨酸被称为“天然阿斯匹林”,广泛用于镇痛解热,抗血凝,能有效预防血栓。长期食用树莓,能有效地保护心脏,预防高血压、血管壁粥样硬化、心脑血管脆化破裂等心脑血管疾病。覆盆子可入药,有明目、补肾作用。归肾,膀胱经。掌叶覆盆子是194种覆盆子中唯一入选《中国药典》,可入药的覆盆子。功效:补肝益肾,固精缩尿,明目。主阳痿早泄,遗精滑精,宫冷***,带下清稀,尿频遗溺,目昏暗,须发早白。
藿香:芳香化浊,和中止呕,发表解暑。用于湿浊中阻,脘痞呕吐,暑湿表证,湿温初起,发热倦怠,胸闷不舒,寒湿闭暑,腹痛吐泻,鼻渊头痛。藿香有杀菌功能,***一叶可除口臭,预防传染病,并能用作防腐剂。夏季用藿香煮粥或泡茶饮服,对暑湿重症,脾胃湿阻,脘腹胀满,肢体重困,恶心呕吐有效。
玫瑰茄:含有丰富的蛋白质、有机酸、维生素C,多种氨基酸,大量的天然维生素和人体所需的矿物质,如铁、钙、磷等。其成份分析如下:还原糖5.7克;蛋白质2.37克;果胶19.8克;苹果酸3.3克;单宁1.09克;花青素14.5克;维生素89毫克/100克,含有人体所必需冬氨酸、谷氨酸、脯氨酸、甘氨酸、丙氨酸、赖氨酸、精氨酸等十七种氨基酸以及抗氧化功能显着的花青素、多元酚、呋喃醛、羟甲基呋喃醛,尤其高含Vc一抗坏血酸。
牛磺酸:一种特殊的氨基酸,是人体必不可少的一种物质,有着平衡健康的奇妙功效。除了眼睛之外,牛磺酸还对其它器官有重要功效。例如,经过研究证实,人体心脏中牛磺酸含量最高。牛磺酸是通过保护心肌而增强心脏功能的。当心肌细胞中钙离子流入量过高时,就会引发冠心病。牛磺酸可以调整心肌细胞中钙离子的量,维持其平衡,实现强心。牛磺酸与心脏的关系已成为全世界重点研究的课题之一。此外,牛磺酸对肺、肝脏、胃肠等都有保护作用。 在日常生活方面,牛磺酸最显著的作用就在于增强免疫力和抗疲劳。牛磺酸可以结合白细胞中的次氯酸并生成无毒性物质,降低次氯酸对白细胞自身的破坏,从而提高人体免疫力。同时,牛磺酸能维持心脏功能,使血液循环正常化,从而消除疲劳生成物,使肌体能有效地产生能量。体内保持恒定的牛磺酸,便能有效地消除疲劳,这是维持人体健康的重要因素。
益生菌:是一类对宿主有益的活性微生物,是定植于人体肠道、生殖***内,能产生确切健康功效从而改善宿主微生态平衡、发挥有益作用的活性有益微生物的总称。人体、动物体内有益的细菌或真菌主要有:酪酸梭菌、乳杆菌、双歧杆菌、放线菌、酵母菌等。当人体住满足够的益生菌时,人就会处于健康的状态,但是一旦体内菌群失去平衡,比如菌种间比例发生大幅变化或者超出正常数值时,那么腹泻、过敏、胃口不佳、疲倦、免疫力低等一系列病症就会随之而来,人体的健康就会亮红灯,而这时适当添加益生菌,协助体内菌群平衡,才能让人重现健康状态。
生产工艺:原料预处理→真空冷冻干燥→气流超微粉碎→微粉包合→压片→灌装→封口包装;
1、原料的处理:(1)、蜂花粉,选择符合<GB/T 30359 蜂花粉>质量要求的花粉,真空冷冻干燥,使其含水量≤5%,再经气流粉碎机超微粉碎,使其目数>400目,备用。
(2)、鹿胶、鹿血、人参(人工种植)、黄精、龙眼肉、佛手、香薷、桔红、胖大海、香橼、莱菔子、黄芥子、紫苏子、橘皮、昆布、山楂、决明子、阿萨伊果、诺丽果浆、杜仲雄花、薏苡仁、甘草、白芷、白果、白扁豆、百合、肉豆蔻、肉桂、余甘子、杏仁(甜、苦)、沙棘、牡蛎、芡实、赤小豆、阿胶、鸡内金、麦芽、枣(大枣、酸枣、黑枣)、罗汉果、郁李仁、金银花、青果、鱼腥草、姜(生姜、干姜)、枳椇子、枸杞子、栀子、砂仁、茯苓、香薷、桃仁、桑叶、桑椹、桔红、桔梗、益智仁、荷叶、莲子、高良姜、淡竹叶、淡豆豉、菊花、菊苣、黄芥子、黄精、紫苏、葛根、黑芝麻、槐米、槐花、蒲公英、蜂蜜、榧子、酸枣仁、鲜白茅根、鲜芦根、薄荷、薤白、覆盆子、藿香、玫瑰茄分别进行预处理,真空冷冻干燥,使其含水量≤5%,再经气流粉碎机超微粉碎,使其颗粒目数>400目,或直接经水(醇)提取得到提取物,备用。
(3)酵母-β提取物、γ-氨基丁酸、复合氨基酸粉、牛磺酸要符合相应的国家标准,益生菌要选择活性在1×1010cfu/g以上的,备用。
(4)将所有原料和辅料按照配方量进行称取,并按照上述加工方式进行预处理,并按照上述生产工艺进行生产,得到规格为0.6g/片的片剂,并按照0.6g/片×60片/瓶的规格进行包装。即得蜂花参精片。
适用人群:适用于阳虚体质、阴虚体质、湿热体质、痰湿体质、气郁体质、免疫力低下人群、***疾病人群、心脑血管疾病人群、营养不良人群、术后人群、气血失调人群、气虚体质人群、美容保健人群、滋补养生人群等。
服用方法:每天2-3次,每次4片。
实施例2 蜂花参精粉的制备
配方:蜂花粉10份,人参2份,黄精2份、复合氨基酸粉4份、牛磺酸3份、酵母β-葡聚糖0.2份、γ-氨基丁酸0.01份
辅料:二氧化硅0.1份、麦芽糊精1份、山梨糖醇2份
工艺:原料预处理→真空冷冻干燥→气流超微粉碎→微粉包合→制粒→灌装→封口包装;
1、原料的处理:(1)、蜂花粉,选择符合<GB/T 30359 蜂花粉>质量要求的花粉,真空冷冻干燥,使其含水量≤5%,再经气流粉碎机超微粉碎,使其目数>400目,备用。
2、人参、黄精、分别进行预处理,真空冷冻干燥,使其含水量≤5%,再经气流粉碎机超微粉碎,使其颗粒目数>400目,或直接经水(醇)提取得到提取物,备用。
3、酵母-β提取物、γ-氨基丁酸、复合氨基酸粉、牛磺酸要符合相应的国家标准,备用。
4、将上述原辅料按照配方量进行称取,并上述方法进行预处理,再按照生产工艺进行生产,按照5g/袋的规格进行包装,即得蜂花参精粉。
适用人群:适用于免疫力低下人群、***疾病人群、心脑血管疾病人群、营养不良人群、术后人群、气血失调人群、气虚体质人群、美容保健人群、滋补养生人群等。
服用方法:每天2-3袋,每次一袋。
以上所述仅是本发明的优选实施方式,应当指出:对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (10)
1.一种含蜂花粉的膳食营养补充剂,其特征在于,包括以下质量份数的原料:蜂花粉1-15份,人参1-5份,黄精1-10份、复合氨基酸粉1-10份、牛磺酸1-10份。
2.根据权利要求1所述的含蜂花粉的膳食营养补充剂,其特征在于:还包括鹿胶1-5份、鹿血1-5份、龙眼肉1-8份、佛手1-6份、香薷1-9份、桔红1-5份、胖大海1-5份、香橼1-8份、莱菔子1-6份、黄芥子1-8份、紫苏子1-6份、橘皮1-6份、昆布1-6份、山楂1-8份、决明子1-7份、阿萨伊果1-8份、诺丽果浆1-6份、杜仲雄花1-6份、薏苡仁1-6份、酵母-β提取物0.1-0.5、γ-氨基丁酸0.01-0.1份、益生菌粉0.01-0.5份,甘草1-5份、白芷1-5份、白果1-5份、白扁豆1-5份、百合1-5份、肉豆蔻1-5份、肉桂1-5份、余甘子1-5份、杏仁1-5份、沙棘1-5份、牡蛎1-5份、芡实1-5份、赤小豆1-5份、阿胶1-5份、鸡内金1-5份、麦芽1-5份、昆布1-5份、枣1-5份、罗汉果1-5份、郁李仁1-5份、金银花1-5份、青果1-5份、鱼腥草1-5份、姜1-5份、枳椇子1-5份、枸杞子1-5份、栀子1-5份、砂仁1-5份、胖大海1-5份、茯苓1-5份、香薷1-5份、桃仁1-5份、桑叶1-5份、桑椹1-5份、桔红1-5份、桔梗1-5份、益智仁1-5份、荷叶1-5份、莱菔子1-5份、莲子1-5份、高良姜1-5份、淡竹叶1-5份、淡豆豉1-5份、菊花1-5份、菊苣1-5份、黄芥子1-5份、黄精1-5份、紫苏1-5份、紫苏籽1-5份、葛根1-5份、黑芝麻1-5份、黑胡椒1-5份、槐米1-5份、槐花1-5份、蒲公英1-5份、蜂蜜1-5份、榧子1-5份、酸枣仁1-5份、鲜白茅根1-5份、鲜芦根1-5份、蝮蛇1-5份、橘皮1-5份、薄荷1-5份、薏苡仁1-5份、薤白1-5份、覆盆子1-5份、藿香1-5份、玫瑰茄1-5份中的一种或几种。
3.根据权利要求1所述的含蜂花粉的膳食营养补充剂,其特征在于:所述膳食营养补充剂的制备工艺流程:原料预处理→真空冷冻干燥→气流超微粉碎→微粉包合→制剂。
4.根据权利要求1所述的含蜂花粉的膳食营养补充剂,其特征在于:所述蜂花粉选自符合<GB/T 30359 蜂花粉>质量要求的花粉,真空冷冻干燥,使其含水量≤5%,再经粉碎机气流超微粉碎,使其目数>400目,备用。
5.根据权利要求1所述的含蜂花粉的膳食营养补充剂,其特征在于:原料处理方法:鹿胶、鹿血、人参、黄精、龙眼肉、佛手、香薷、桔红、胖大海、香橼、莱菔子、黄芥子、紫苏子、橘皮、昆布、山楂、决明子、阿萨伊果、诺丽果浆、杜仲雄花、薏苡仁、甘草、白芷、白果、白扁豆、百合、肉豆蔻、肉桂、余甘子、杏仁、沙棘、牡蛎、芡实、赤小豆、阿胶、鸡内金、麦芽、枣、罗汉果、郁李仁、金银花、青果、鱼腥草、姜、枳椇子、枸杞子、栀子、砂仁、茯苓、香薷、桃仁、桑叶、桑椹、桔红、桔梗、益智仁、荷叶、莲子、高良姜、淡竹叶、淡豆豉、菊花、菊苣、黄芥子、黄精、紫苏、葛根、黑芝麻份、黑胡椒、槐米、槐花、蒲公英、蜂蜜、榧子、酸枣仁、鲜白茅根、鲜芦根、蝮蛇、橘皮、薄荷、薏苡仁、薤白、覆盆子、藿香、玫瑰茄分别进行预处理,真空冷冻干燥,使其含水量≤5%,再粉碎机经气流超微粉碎,使其颗粒目数>400目,或直接经水/醇提取得到提取物,备用。
6.根据权利要求1所述的含蜂花粉的膳食营养补充剂,其特征在于,所述酵母-β提取物、γ-氨基丁酸、复合氨基酸粉、牛磺酸要符合相应的国家标准,益生菌活性在1×1010cfu/g以上。
7.根据权利要求4或5所述的含蜂花粉的膳食营养补充剂,其特征在于:真空冷冻干燥,制冷温度要≤-50℃~-60℃,真空度80pa~100pa,冻干后水分≤5%。
8.根据权利要求3所述的含蜂花粉的膳食营养补充剂,其特征在于:微粉包合,“微粉”为超微粉碎后的粉体,粉体不仅会产生静电吸附成团状,而且水冲服时极易成团,在不引入外来物质改变原有粉体成分构成的前提下,通过“唤醒”粉体自身物质的粘性,将微粉包合成80~100目的颗粒。
9.根据权利要求1所述的含蜂花粉的膳食营养补充剂,其特征在于:还包括制备不同剂型所需的药学上可接受的辅料/添加剂,如润滑剂、抑菌剂等。
10.根据权利要求1所述的含蜂花粉的膳食营养补充剂,其特征在于:所述含蜂花粉的膳食营养补充剂为颗粒剂、胶囊剂、片剂、丸剂、膏剂或口服溶液剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710217393.5A CN107019186A (zh) | 2017-04-05 | 2017-04-05 | 一种含蜂花粉的膳食营养补充剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710217393.5A CN107019186A (zh) | 2017-04-05 | 2017-04-05 | 一种含蜂花粉的膳食营养补充剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107019186A true CN107019186A (zh) | 2017-08-08 |
Family
ID=59527756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710217393.5A Pending CN107019186A (zh) | 2017-04-05 | 2017-04-05 | 一种含蜂花粉的膳食营养补充剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107019186A (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107927769A (zh) * | 2017-12-12 | 2018-04-20 | 四川旭阳药业有限责任公司 | 一种复合保健品及其制备方法 |
CN108741027A (zh) * | 2018-05-25 | 2018-11-06 | 何会平 | 一种运动营养咀嚼片及其制备方法 |
CN109007830A (zh) * | 2018-08-01 | 2018-12-18 | 丽睿客信息科技(北京)有限公司 | 一种食品组合物及其制备方法和应用 |
CN109198015A (zh) * | 2018-07-05 | 2019-01-15 | 内蒙古云现代电子商务有限公司 | 一种用奶酒和中药酿制的露酒及其配制方法 |
CN109673986A (zh) * | 2019-01-28 | 2019-04-26 | 广州佳明食品科技有限公司 | 一种葛根复合粉及其制备方法 |
CN110772595A (zh) * | 2019-11-18 | 2020-02-11 | 黄泽昊 | 一种药食同源组合物及其制备方法和应用 |
CN115429832A (zh) * | 2022-10-09 | 2022-12-06 | 北京知蜂堂健康科技股份有限公司 | 一种缓解变应性鼻炎的组合物及其制备方法和应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101897432A (zh) * | 2009-05-30 | 2010-12-01 | 潘健 | 一种具有降血糖功能的保健品 |
CN102210426A (zh) * | 2011-05-06 | 2011-10-12 | 湖南明园蜂业科技有限公司 | 一种具有润肠作用的花粉膏及其制备方法 |
CN102228242A (zh) * | 2011-06-17 | 2011-11-02 | 肖天存 | 一种复合蔬菜保健品及其制备方法 |
CN102847157A (zh) * | 2012-10-12 | 2013-01-02 | 潍坊复能肾病研究院 | 通过靶向导入肾区复能而治疗肾病的中药组合物 |
CN104687062A (zh) * | 2015-03-11 | 2015-06-10 | 陈航 | 一种辅助降血脂的组合物及其制备方法、制剂与应用 |
CN104873647A (zh) * | 2015-05-04 | 2015-09-02 | 江苏江大源生态生物科技有限公司 | 一种玛咖粉胶囊及其制备方法 |
CN105942080A (zh) * | 2016-04-21 | 2016-09-21 | 修正健康饮品股份有限公司 | 玛咖黄精植物饮料的配方及其制作方法 |
-
2017
- 2017-04-05 CN CN201710217393.5A patent/CN107019186A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101897432A (zh) * | 2009-05-30 | 2010-12-01 | 潘健 | 一种具有降血糖功能的保健品 |
CN102210426A (zh) * | 2011-05-06 | 2011-10-12 | 湖南明园蜂业科技有限公司 | 一种具有润肠作用的花粉膏及其制备方法 |
CN102228242A (zh) * | 2011-06-17 | 2011-11-02 | 肖天存 | 一种复合蔬菜保健品及其制备方法 |
CN102847157A (zh) * | 2012-10-12 | 2013-01-02 | 潍坊复能肾病研究院 | 通过靶向导入肾区复能而治疗肾病的中药组合物 |
CN104687062A (zh) * | 2015-03-11 | 2015-06-10 | 陈航 | 一种辅助降血脂的组合物及其制备方法、制剂与应用 |
CN104873647A (zh) * | 2015-05-04 | 2015-09-02 | 江苏江大源生态生物科技有限公司 | 一种玛咖粉胶囊及其制备方法 |
CN105942080A (zh) * | 2016-04-21 | 2016-09-21 | 修正健康饮品股份有限公司 | 玛咖黄精植物饮料的配方及其制作方法 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107927769A (zh) * | 2017-12-12 | 2018-04-20 | 四川旭阳药业有限责任公司 | 一种复合保健品及其制备方法 |
CN108741027A (zh) * | 2018-05-25 | 2018-11-06 | 何会平 | 一种运动营养咀嚼片及其制备方法 |
CN109198015A (zh) * | 2018-07-05 | 2019-01-15 | 内蒙古云现代电子商务有限公司 | 一种用奶酒和中药酿制的露酒及其配制方法 |
CN109007830A (zh) * | 2018-08-01 | 2018-12-18 | 丽睿客信息科技(北京)有限公司 | 一种食品组合物及其制备方法和应用 |
CN109673986A (zh) * | 2019-01-28 | 2019-04-26 | 广州佳明食品科技有限公司 | 一种葛根复合粉及其制备方法 |
CN110772595A (zh) * | 2019-11-18 | 2020-02-11 | 黄泽昊 | 一种药食同源组合物及其制备方法和应用 |
CN115429832A (zh) * | 2022-10-09 | 2022-12-06 | 北京知蜂堂健康科技股份有限公司 | 一种缓解变应性鼻炎的组合物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107019186A (zh) | 一种含蜂花粉的膳食营养补充剂 | |
CN104799146A (zh) | 一种改善亚健康的功能性营养食品组合及其制备方法 | |
CN104825970A (zh) | 一种诺丽果浆保健品 | |
CN105901715A (zh) | 一种鹿胶糕及其制备方法 | |
CN104873763A (zh) | 一种调理气虚体质的保健品 | |
CN106889233A (zh) | 一种袋泡参苓白术茶及其制备方法 | |
CN105233100A (zh) | 一种治疗糖尿病的饮料及其制备方法 | |
CN110327421A (zh) | 一种适合宇航员具有提高精力和协调人体各器官功能的组合物 | |
CN106333010A (zh) | 一种袋泡减肥瘦身茶及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN104069390A (zh) | 一种用于增肥的中药汤剂 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN105288597B (zh) | 一种治疗皮肤色素沉着的药物 | |
CN103125937A (zh) | 一种解酒护肝剂及其制备方法 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN104115960A (zh) | 一种鲜芦根凉茶饮料 | |
CN102599595B (zh) | 具有降血脂作用的保健饮品、中药及制备方法 | |
CN114651968A (zh) | 一种宿醉解酒组合物配方及其制备方法 | |
CN102579872B (zh) | 一种具有减肥功效的药物组合物 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 | |
CN105638961A (zh) | 一种含有苎麻叶的黑茶组合物及制备方法 | |
CN104984141A (zh) | 一种治疗便秘的方剂及其制备方法 | |
CN110679935A (zh) | 一种牛蒡人参精华膏及其制备方法 | |
KR20210041387A (ko) | 갈화 추출물 및 차전자피 분말을 함유한 숙취해소용 천연차 및 그 제조방법 | |
CN109289017A (zh) | 用于清理血管和血液的组合物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170808 |
|
RJ01 | Rejection of invention patent application after publication |